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Abstract 
An Examination of the Factor Structure  
of the SCI-PANSS 
Paul Thomas Dudek 
Michael Lowe, Ph.D. 
 
 
 
 
 Schizophrenia is a debilitating disorder with far reaching effects on 
individual functioning. The characteristic symptoms include positive 
symptoms which are described as psychosis and bizarre behavior. Then there 
are the negative symptoms which are more numerous in presentation. 
Negative symptoms include problems in communication, affect, cognition, 
and behavioral control. While the positive symptoms are more readily 
defined, the negative symptoms are less so. All of these symptoms present in 
complex patterns, which has led to difficulty in the accurate measurement of 
symptom severity. The SCI-PANSS has sought to measure the severity of 
schizophrenic symptoms.  There has been considerable debate centered on 
the number and composition of dimensions that make up the phenomenon of 
schizophrenia. The goals of this project were (1) to examine the factor 
structure of the PANSS rating scale in a sample of individuals diagnosed 
with schizophrenia, and, (2) simultaneously compare on a single sample the 
obtained factor structure with several previously derived multi-factorial 
models of the SCI-PANSS.  
 This study describes a latent structure of SCI-PANSS symptoms using 
an exploratory factor analysis (EFA). This model was compared to previously 
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derived models through a confirmatory factor analysis (CFA). Previous 
models have been described using a variety of patient samples. This left the 
competing models vulnerable to variation caused by these varied samples. 
This study improves upon the present literature by removing this confound 
through the comparison of multiple models on one sample. 
 An EFA was conducted on a large sample of subjects diagnosed with 
schizophrenia. This analysis produced a five factor solution. These 
dimensions include: positive symptoms, negative symptoms, cognitive 
symptoms, an excitement dimension, and an anxiety/depression component. 
 This derived factor solution was compared to a number of other 
competing models that have been derived through other factor analytic 
studies. These included a null model, a three and four factor solution, several 
five factor models, and a seven factor model. While none of these models met 
adequate fit, the results suggest that a pentagonal model reflects the latent 
structure of schizophrenia. Implications of these findings are discussed with 
recommendations to improve model specification. 
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I. Introduction 
 
 The measurement of symptom severity is an essential aspect of clinical 
psychology and psychiatry. However, the measurement of symptomatology in 
psychology is rarely as simple as indicating the presence or absence of a 
symptom. More often symptoms present along a spectrum of intensity. To 
complicate matters, symptoms generally do not occur in isolation. Disorders 
are defined by a set of these correlating features. The design of any 
instrument intended to measure symptom severity must not simply define 
these features but should also reflect the natural or latent structure of these 
symptoms as they occur. 
 Andreasen et al. (1994) have outlined the goals of the study of 
psychopathology. The questions they ask are as follows: what are the 
characteristic symptoms? The symptoms of the disorder must be identified 
and defined. What are the boundaries of the disorder?  A clinician needs to be 
able to accurately determine when a disorder exists and when it does not. 
What are the subtypes?  Some disorders evidence multiple clinical 
presentations, and these various presentations must be defined. What are the 
characteristics of the disorder’s longitudinal course? Some disorders change 
in presentation over the life span and the presentation may change from an 
acute stage to a chronic stage. What is the link between clinical presentation 
and neural mechanisms? The etiology of a disorder can often shape treatment 
and prognosis. And finally, can it be explained parsimoniously? The validity 
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of the conceptualization of any disorder is improved by clear well defined 
descriptions. Each of these questions must be given consideration in the 
design of instruments to measure psychopathology accurately and reliably. 
Instruments used in the measurement of psychopathology and its severity 
should reflect the current universe of knowledge and understanding of any 
particular disorder. 
 
Aims of this Study 
 This study seeks to accomplish several goals. The study will first 
outline the difficulties that have emerged in the conceptualization of 
symptom dimensions in a complex and debilitating psychiatric disorder, 
schizophrenia. Additionally, limitations of instruments designed to assess the 
positive and negative symptoms of schizophrenia will be described. This 
study will attempt to demonstrate that the dichotomous categorization of 
these symptoms is problematic and that such categorization inadequately 
describes the multi-faceted nature of the disorder. The development and 
psychometric properties of the SCI-PANSS, an instrument designed to correct 
for limitations of prior assessment tools of schizophrenia symptoms will then 
be described. The factorial validity of this instrument however, has been the 
subject of considerable debate. Numerous models of the latent structure of 
the SCI-PANSS have emerged in the psychometric literature, but none have 
been conclusive. The main goals of this project are (1) to examine the factor 
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structure of the PANSS rating scale in a sample of individuals diagnosed 
with schizophrenia, and, (2) simultaneously compare on a single sample of 
individuals with schizophrenia, the obtained factor structure with several 
previously derived multi-factorial models of the SCI-PANSS identified in the 
literature.  
 
The Background and Significance of Schizophrenia 
As a clinical syndrome, schizophrenia is a psychiatric disorder that 
presents in a wide variety of manifestations.  Although it is possible that a 
single etiological or pathogenic process accounts for this diversity, it is very 
likely that the syndrome has multiple courses of illness, which accounts for 
the variety of presentations. An individual diagnosed with schizophrenia is 
usually identified by the observation of psychotic symptoms, delusional 
beliefs, and bizarre behavior. However, many, if not most, patients also have 
negative symptoms. These negative symptoms can include low levels of 
emotional arousal, mental activity, and social drive.  Given their presence 
throughout the course of the illness, these negative symptoms are often the 
most debilitating aspects of the long-standing impairment observed in 
patients with schizophrenia.   
According to the DSM-IV (APA,1994), the characteristic symptoms of 
schizophrenia involve a range of cognitive and emotional dysfunction that 
effect perception, inferential thought, language, attention, behavioral 
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monitoring and control, affect, and volition. There is no single symptom that 
is pathognomonic to schizophrenia. Instead, the syndrome is a constellation 
of signs and symptoms that is related to impairment in social and 
occupational functioning. The characteristic or primary symptoms of 
schizophrenia can be conceptualized as falling into two broad types, positive 
or negative. The positive symptoms include delusions, hallucinations, 
disorganized speech, and disorganized or catatonic behavior. The negative 
symptoms, of which the DSM-IV identifies three as specific criterion, are 
symptoms which reflect an absence of cognitive abilities which are normally 
present in most individuals. These include affective flattening, alogia, and 
avolition. A number of other negative symptoms are included as associated 
symptoms, but are not necessarily identified as specific criterion for the 
disorder. While positive symptoms are often readily evident in presentation, 
the negative symptoms are more difficult to evaluate. This is associated with 
the understanding that negative symptoms occur along a continuum with 
normality, are nonspecific, and may be due to other factors such as a 
consequence of the positive symptoms, medication side effects, or 
demoralization related to behavior secondary to the positive symptoms.  
In order to meet the criteria for the diagnosis of schizophrenia, an 
individual must present with two or more of the characteristic symptoms for 
more than one month. During a significant portion of the time since the onset 
of these symptoms, the individual should demonstrate difficulties in 
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functioning in one or more major areas of life functioning. These can include 
interpersonal relationships, self care, and occupational functioning. 
Additionally, there needs to be continuous signs that the disturbance persists 
for at least six months. In most cases, these signs will predominantly be the 
negative symptoms. As exclusionary criteria, the dysfunction cannot be due 
to an affective disorder, substance abuse, or the direct effects of a medical 
condition. Depending upon which of the characteristic symptoms is most 
significant in presentation, schizophrenia can also be identified by sub-type 
in the DSM-IV system. These sub-types include paranoid, disorganized, 
catatonic, undifferentiated, or residual. The paranoid, disorganized, and 
catatonic sub-types are related to a dominance of a specific positive symptom. 
The presence of characteristic symptoms, but no one symptom is dominant 
note the undifferentiated sub-type. The residual subtype presents with a lack 
of positive symptoms, but there is evidence of the presence of negative 
symptoms. Often this is the postdromal presentation of the disorder. 
Schizophrenia is not only debilitating to the individual but it is also a 
syndrome with a profound influence on public health. Schizophrenia has been 
called “arguably the worst disease affecting mankind, even AIDS not 
excepted” (Carpenter & Buchanan, 1994).  The worldwide lifetime prevalence 
of the disorder is estimated between 0.20-1% across diverse geographic, 
cultural, and socioeconomic categories.  In some areas, the prevalence of the 
disorder has been reported to be as high as 2% of the population (APA, 1994). 
PANSS Factor Structure   6 
According to the DSM-IV (APA, 1994), the incidence rate of schizophrenia is 
estimated to be approximately 1 per 10,000 individuals per year. The onset of 
the illness occurs relatively early in life, predominately in the mid- to early 
twenties. While the onset may be acute or insidious, a majority of cases are 
marked by a slow and gradual development. Significant others often have 
difficulty understanding these changes and family discord often follows. 
Eventually, most individuals decompensate into an active phase, often 
marked by psychosis. For many, it is not until this point that they enter into 
treatment for the syndrome. Most patients suffer from long-lasting adverse 
effects such as impaired social, familial, and vocational functioning as well as 
the internal distress caused by the symptoms.  While some individuals suffer 
through a chronic, unremitting illness, others follow a course of periodic 
exacerbation and remissions. Complete remission or a return to pre-morbid 
functioning is probably not common with schizophrenia. The chronic nature 
of schizophrenia may be accounted for by the abnormal brain functions found 
when compared to control subjects. As a group, structural abnormalities in 
the brain have been found consistently in schizophrenic individuals. Most 
commonly, the abnormalities are the enlargement of the ventricular system 
and of the prominent sulci of the brain. Specifically, enlargement of the 
ventricular system has been associated with negative symptoms. 
Abnormalities of the prominent sulci have been correlated with the 
presentation of positive symptoms such as psychosis. 
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In 1990, the direct and indirect costs of schizophrenia in the United 
States amounted to an estimated $33 billion. It was estimated at that time 
that treatment costs accounted for 2.5 percent of the total U.S. healthcare 
expenditure. Inpatient treatment is still common, despite 
deinstitutionalization in the 1960’ and 70’s. Many communities are ill 
prepared to provide adequate long term care and shelter for patients with 
schizophrenia.  Even more troubling is the stigma associated with 
schizophrenia, which can create more difficulty in creating treatment 
programs with ready access for patients. Even the most up-to-date 
treatments are only palliative, and a significant fraction of patients with this 
disorder are refractory to any known treatment (Kane, 1996).  A majority of 
psycho-pharmacological treatments available target the positive symptoms 
and have a significant side effect profile. It has only been in the last decade 
that medications have entered the market that has demonstrated significant 
effects in the treatment of both positive and negative symptoms. Finally, 
given that between one third and one half of homeless Americans have been 
estimated to suffer from schizophrenia (Carpenter & Buchanan, 1994), the 
scope of the problem of providing care for these patients is clearly widespread 
and far reaching. 
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The Positive Symptoms 
 The positive symptoms have historically been conceptualized as 
hallucinations, delusions, thought disorders, and bizarre behavior. 
Hallucinations are the abnormal perception of stimuli that in reality do not 
exist. Delusions represent an abnormality in inferential thought where the 
perceptions are normal but the interpretation is aberrant. Problems 
associated with thought disorders are related to the distortion of normal 
speech that occurs in abundance. That is, an individual presents with a 
pervasive problem in the production, comprehension, and logic of speech that 
is not related to an organic cause. While historically thought disorders have 
been associated with positive symptoms, increasing numbers of authors have 
described them as negative symptoms (Klosterkotter, et al., 1995). Bizarre 
behavior is the aberration in behavioral organization and control where the 
individual performs inappropriate social and sexual behaviors as well as 
perseverative acts. Collectively, the positive symptoms are usually described 
as being distinctly absent or present given the ease in observing these types 
of behaviors (Andreasen, 1990). 
 The positive symptoms of schizophrenia are readily assessed, leaving 
little difficulty for researchers and clinicians in making reliable and valid 
decisions as to their presence (Johnstone, 1989). In clinical diagnosis, these 
positive symptoms have been utilized as first rank symptoms of 
schizophrenia (APA,1994). First rank symptoms are those which are required 
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to be present in order to meet the full criteria for diagnosis. However, some 
have suggested the positive symptoms have begun to play too predominant a 
role in the description of schizophrenia. Many authors believe that since 
positive symptoms are transitory and episodic, whereas negative symptoms 
tend to be stable over time, more emphasis should be shifted to the multi-
dimensional nature of the disorder (Klosterkotter, et al., 1995). In addition, 
these symptoms may have too low a base rate to be used in isolation for 
diagnostic purposes. This is especially relevant given the transitory nature of 
positive symptoms being dominant primarily in acute phases and the finding 
that they are not predictive of long term outcome (Klosterkotter, et al., 1995). 
 
The Negative Symptoms 
 Negative symptoms are a complex pattern of behavioral and emotional 
states (Mundt, Kasper, & Huerkamp, 1989). The negative symptoms may be 
an expression of an elementary deficiency of mental or cognitive functions, 
the reactions and attitudes reflective of personality styles, and the 
presentation of medication side effects. It has been generally accepted that 
positive and negative symptoms are independent variables with differing 
underlying pathologies and time courses. Rarely do positive symptoms 
correlate with negative symptoms (Crow, 1989). Often, negative symptoms 
are found to exist prior to the onset of positive symptoms, but do not come 
into clinical awareness until positive symptoms surface (Kloskotter, et al., 
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1995). Primary negative symptoms are those whose causality is attributed 
directly to the disorder. Secondary negative symptoms would be those 
associated to the effect of medication. 
 Due to the great variability in the presentation of negative symptoms 
in psychiatric patients, the use of negative symptoms is problematic in 
discriminating schizophrenic from non-schizophrenic patients (Klosterkotter, 
et al., 1995). Only thought blocking and inadequate affect appears 
consistently as a negative symptom across many schizophrenic patients, with 
the remainder varying widely (Mundt, Kasper, & Huerkamp, 1989). Also, 
withdrawal behaviors, apprehension, and resignation features often overlap 
with other disorders, especially those in the depressive spectrum (Mundt, 
Kasper, & Huerkamp, 1989). It is this overlap of negative symptoms with 
depressive symptoms and other problems that has given positive symptoms 
their discriminative power.  
Thus, negative symptoms seem to have much in common with 
symptoms of multiple disorders (Mundt, Kasper, & Huerkamp, 1989). While 
many negative symptoms occur most frequently in individuals suffering from 
schizophrenia, they present quite commonly in the mood disorders and 
organic disorders. They are also found in the anxiety disorders, phobias, and 
personality disorders with lesser frequency. Mundt and his colleagues (1989) 
report that at any given time point, seven percent of individuals without a 
psychiatric diagnosis present with negative symptoms. This would be a 
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particularly large problem if the negative symptoms were used in isolation to 
describe schizophrenia. The problem is overcome by the inclusion of positive 
symptoms in defining schizophrenia. However, this same overlap among the 
negative symptoms in multiple disorders is also responsible for the emphasis 
placed on the positive symptoms for diagnosis. This, as noted earlier, has 
generated concern that the negative symptoms are given too little 
consideration in comparison to their pervasive nature in schizophrenia. 
 Negative symptoms have not readily lent themselves to measurement, 
especially in terms of severity. Problems with speech and incongruity of affect 
have been difficult to rate due to problems in defining the limits of normality 
of these features (Johnstone, 1998). Given the overlap of negative symptoms 
in their presentation with non-psychotic diagnosis, it has often been difficult 
to differentiate which symptoms are due to schizophrenia, depression, and 
even medication side effects (Wolthaus, et al., 2000). 
 Negative symptoms posses several unique features when attributed 
specifically to schizophrenia. In acute or first episodes, negative symptoms 
are sparse and are linked tightly to the presence of other manifestations of 
psychosis, notably the delusions and hallucinations (Moller, 1995). However, 
the idiosyncratic presentation of negative symptoms appears to be more 
stable in chronic and sub-acute patient samples, whereas positive symptoms 
are transitory and episodic in nature. Additionally, individuals with 
schizophrenia have proportionately greater abnormalities within the 
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ventricular system of the brain (d’Amato, et al., 1992) which has been 
associated with the presentation of negative symptoms. Positive symptoms, 
however, have been associated with abnormalities in the sulci of the brain. 
 The syndrome of schizophrenia is comprised of a complex pattern of 
symptoms. Certain features, those identified as positive, lend themselves to 
be readily identified by their uniqueness and gross deviation from normal 
perception. Indeed, schizophrenia is classified in the DSM-IV with related 
disorders under the general order of “Psychotic Disorders”. Though merely a 
classification title, the name can be related to an emphasis on positive 
symptoms. However, schizophrenia is comprised of more than just the 
positive symptoms. It is the negative symptoms that present in a more 
chronic fashion, are more resistant to treatment effects, and are related to 
the long term debilitation of the individual. While the negative symptoms are 
generally well defined, how they are incorporated within the structure of 
schizophrenia is in debate. By understanding the latent structure of 
schizophrenia symptoms and designing instruments which accurately reflect 
this structure, researchers and clinicians can be more sensitive to clinical 
presentations of the disorder as well as the overt and subtle effects of 
treatment. 
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Difficulties with the Conceptualization of Positive and Negative Symptoms 
 The historical origins of the use of positive and negative terminology 
can be attributed to Hughlings Jackson in the 1880’s (Moller, 1995). Jackson 
was a British neurologist who developed these concepts in order to delineate 
from primary and secondary neurological phenomena. Later, Kraepelin 
(1919) and Bleulur (1950), using a similar conceptualization of the disorder, 
described a core set of symptoms which were the modern equivalent of the 
negative symptoms of schizophrenia (Moller, 1995). Gradually, Kraepelin and 
Bleulur’s conceptualization was replaced by an emphasis on the productive 
features of schizophrenia. It was these productive, or positive, features that 
became a prerequisite for the diagnosis of schizophrenia as formalized by the 
Diagnostic and Statistical Manual model (American Psychiatric Association, 
1994). 
 Throughout this history, the definitions of the positive and negative 
symptoms of schizophrenia have remained fundamentally the same (Moller, 
1995).  Positive symptoms are indicated by the presence of a behavioral 
function not normally present in an individual. Negative symptoms are those 
marked by the absence of a behavioral function usually present in an 
individual. However, the classification of specific symptoms has varied across 
time and authors (Moller, 1995). Those symptoms that have been universally 
accepted as positive features of schizophrenia include hallucinations and 
delusions, and most authors agree that blunt affect and poverty of speech are 
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representative negative symptoms. However, more problematic are those 
symptoms such as thought disorders, bizarre behavior, and inappropriate 
affect, each of which has been described as either positive or negative 
symptoms across various studies. This inconsistency reflects one of the 
fundamental goals of this paper; that the dichotomous categorization of these 
problematic symptoms of positive or negative does not reflect the complex 
multi-dimensional nature of schizophrenia. 
 Crow (1980) was most responsible for the modern clinical utilization of 
the terms positive and negative symptoms. Crow proposed a dichotomous 
model of schizophrenia. Type I schizophrenia was defined by Crow as 
consisting of predominate positive symptoms, acute onset, good pre-morbid 
adjustment, good response to treatment, intact cognition, intact brain 
structure, a mechanism that is neuro-chemical (dopaminerigic) in action, and 
is reversible. Type II schizophrenia was described as being marked by a 
dominance of negative symptoms, insidious onset, poor pre-morbid 
adjustment, poor response to treatment, impaired cognition, structural brain 
abnormalities, an underlying neural mechanism of neural loss and is 
therefore irreversible. Crow’s “dual process” model provided a parsimonious 
explanation of the schizophrenia phenomenon. The simplicity and clarity of 
the model initiated a great deal of research on the symptoms of schizophrenia 
throughout the 1980’s. 
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 However, there were two fundamental problems with Crow’s dual 
process theory (Andreasen, et al., 1994). First, there was no clear method of 
measuring positive and negative symptoms. Second, the theory failed to 
indicate if those symptoms which overlapped in both dimensions should be 
considered as independent or dependent constructs from positive or negative 
symptoms. Additionally, the model failed to define specific sets of symptoms 
that should be used to reliably describe the syndromes. Crow later modified 
the dual process theory by describing the positive and negative symptoms as 
independent, non-overlapping constructs. However, additional research 
indicated that individuals presented with a great deal of overlap of both types 
of symptoms (Andreasen, et al., 1994). 
 The of assessment of positive and negative symptoms as independent 
sub-types of schizophrenia persisted due to its utility in describing a broad 
range of symptoms regardless of the oversimplification this caused. 
Additionally, many of the instruments developed to measure symptoms of 
schizophrenia treated the features as occurring within two distinct 
syndromes (Andreasen, et al., 1994). This contradicted the abundance of 
literature which indicated that there is a considerable degree of overlap 
within these syndromes. For historical and clinical reasons, cognitive 
disorganization symptoms were often grouped with the positive symptoms. 
The rationale behind this was that these particular features are florid, and 
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like hallucinations, tend to be a presenting problem that brings a patient to 
medical attention. 
 Shortcomings with conceptualizations were not the only difficulty in 
measuring positive and negative symptoms. Prior to the late 1980’s, 
difficulties in reliably and validly measuring these symptoms became 
evident. The instruments that grew out of the dual process model, though 
well conceived, lacked standardization and the psycho-metric properties to 
adequately measure these symptoms (Kay, Fiszbein, & Opler, 1987). It was 
not until this time frame that a number of standardized instruments were 
published which had a positive effect on reliable measurement (Moller, 1995). 
Examples of such instruments include The Scale for the Assessment of 
Negative Symptoms (SANS)(Andreasen, 1983) and The Scale for the 
Assessment of Positive Symptoms (SAPS) (Andreasen,1984). Both of these 
instruments are rating scales completed by clinicians based on observation of 
individuals and noted the presence or absence of symptoms. Each of these 
instruments demonstrated a satisfactory level of internal consistency, 
reliability, and validity (Andreasen, et al., 1994). 
 However, these instruments still regarded positive and negative 
symptoms on two separate dimensions. In nearly all studies involving a broad 
spectrum of negative symptoms, at least three separate dimensions emerged 
with positive and negative symptoms as two factors in addition to a 
disorganized dimension (Moller, 1995). Numerous factor analytic studies 
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have demonstrated this three-factor solution which is highly reproducible 
(Andreasen, et al., 1995) and has emerged in a variety of research settings 
using various instruments (Thompson & Meltzer, 1993). The positive 
dimension is clearly delineated by delusions and hallucinations. Features 
such as avolition, anhedonia, and affective flattening define the negative 
dimension. The third dimension generally includes symptoms associated with 
thought disorder such as poverty of speech, blocking, perseveration, and 
inattention. This third dimension has also been referenced as the 
disorganization dimension. 
 These three factors appear to be uncorrelated and follow separate 
longitudinal courses as the illness progresses (Arndt, et al., 1995). Negative 
symptoms showed little variation over time, being present in acute and 
chronic stages. Positive symptoms showed the most rapid amount of change 
due to their quick response to medication treatments. Disorganized 
symptoms however, showed the greatest amount of variability over time. 
As such, the current model of schizophrenic symptoms assumes a 
dimensional approach (Andreasen et al., 1994). This approach differs in that 
symptoms, not patients, are separated into groups that define properties that 
co-occur within individuals. This allows for the description of disorders to be 
comprised of multiple domains of symptoms which can present in individuals 
in a broad variety of combinations. Dimensions also differ from categorical 
sub-types, in that dimensional approaches allow for overlap within an 
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individual while subtypes force individuals into independent non-overlapping 
sets. In addition, dimensional approaches are continuos and allow for 
different degrees of severity (Andreasen et al., 1995). 
Some have suggested that in light of the limitations of the 
conceptualization of these symptoms and the categorization of them by 
measurement tools, three factors may not be adequate in describing 
schizophrenia, or in addressing the role of symptom overlap (Rey, et al., 
1994). Rey and his colleagues followed 163 schizophrenic patients over the 
course of five years and tracked symptomology with a wide range of 
measurements of pathology related to the psychotic disorders. They revealed 
a five-factor model of the disorder that remained stable over the five years. 
These five factors were: 
1. Reduced Affect: blunt affect, poverty of speech, and other negative 
symptoms. 
2. Anhedonia: avolition, anhedonia, and inattention 
3. General Neurotic: anxiety and depression related symptoms 
4. General Positive: excitability and incoherent speech 
5. Delusions and Hallucinations 
It has been strongly argued in the most recent literature that a five 
component structure would be more in line with the complexity of 
schizophrenic symptoms and may be more useful in describing effects found 
in treatment studies (Wolthus, et al., 2000). This argument becomes more 
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salient with a more in depth understanding of the specific nature of the 
positive and negative symptoms of schizophrenia. 
 
Further Considerations of the Schizophrenia Construct 
 Schizophrenia is demographically and symptomatically heterogeneous 
(Andreasen, et al., 1995). Two individuals suffering from schizophrenia may 
have totally different and non-overlapping patterns of symptoms. 
Additionally, positive and negative symptoms do not posses stable clinical 
presentations in either the short or long term course of the disorder. Thus, 
they should not be taken as indicators of specific biological or 
phenomenological subtypes (Moller, 1995). This complexity reinforces the 
concept that the schizophrenias are a multi-dimensional construct.  
 In most modern diagnostic systems, psychiatric disorders are 
conceptualized as multi-layered, inter-connected constructs (Wing,1989).  
Additionally, a vertical hierarchical model is evident in most diagnostic 
systems, including the DSM-IV system (APA,1994). Diagnostic systems give 
priority to symptoms associated with individual disorders. That is, diagnostic 
systems generally describe symptoms with a relative importance to the 
disorder. Symptoms can range from being necessary and required to being of 
tertiary importance. The highest priority is given to organic symptoms which 
are those related to lesions in the brain. First rank symptoms are those 
symptoms that do not have a clear physiological cause and are required to be 
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present to meet the criteria for diagnosis. Severe affective symptoms are 
generally accepted as the third level of priority as they often occur as a result 
of the presence of first rank symptoms. Anxiety / obsessive features are 
considered to be at the fourth level. These symptoms also occur secondary to 
the first rank symptoms but are less frequent across disorders. Finally there 
are non-specific features which are usually not used in the criteria for the 
disorders but are problems associated with the effects of the symptoms. The 
higher order features are associated with lower ones, but not vice versa. In 
schizophrenia, the key first rank symptoms such as delusions and 
hallucinations often disappear with treatment or as the disorder progresses, 
but lower level ones, specifically the negative symptoms, often persist (Wing, 
1989). Frequently, non-specific and affective symptoms such as depression 
recur as prodromal symptoms of relapse in schizophrenia (APA, 1994). 
The development of any instrument to measure the symptoms of 
schizophrenia must be sensitive to a number of issues that arise out of this 
complex disorder. First, this instrument must be reflective of the 
independent, multi-dimensional nature of the disorder. Second, the 
instrument should possess adequate sensitivity to allow for the control, or 
partialing out, of variation explained by symptom overlap. The overlap of 
symptoms often contributes to intensifying overall symptom severity. By 
controlling for this overlap, the true severity of any one symptom can become 
more apparent. Third, clear operational definitions and discreet points of 
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measurement must guide the evaluation of constructs.  Fourth, the 
constructs must be able to be measured in a standardized, reliable, and 
psychometrically sound manner. Finally, the instrument must be sensitive to 
the overt and the subtle changes that occur through the disorder’s 
longitudinal course and from therapeutic change.  
These basic considerations guided the authors of the Structured 
Clinical Interview for the Positive and Negative Syndrome Scale (SCI-
PANSS) (Kay, Opler, Fiszbein, 1992). The SCI-PANSS has demonstrated a 
resiliency to many of these demands. However, as a focal point of this paper, 
the dimensional or factor structure of the SCI-PANSS has been a continued 
source of debate. 
 
The Conceptual Foundation of the SCI-PANSS 
 A number of critiques and discussion of limitations exists regarding 
the many instruments used to measure positive and negative symptoms in 
schizophrenia prior to the SCI-PANSS (Kay, Fiszbein, Opler, 1987). Many of 
these instruments measured the presence of a symptom, but not the severity, 
which complicated their ability to be sensitive to therapeutic changes. Some 
scales demonstrated an imbalance in the number of items representative of 
positive and negative symptoms. Most scales were inapplicable to both 
typological and dimensional assessment of syndromes. None of the scales 
included a measurement or ratio of the preponderance of positive to negative 
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syndromes, nor did any of the scales include a measurement of general 
psychopathology. 
 The authors of the SCI-PANSS sought to overcome these limitations, 
while at the same time attempting to achieve the requisite goals of such an 
instrument. To achieve this, three principals guided the selection of items for 
the SCI-PANSS (Kay, Opler, Lindenmayer, 1989). The items had to be 
consistent with the theoretical concepts of positive and negative symptoms 
and include symptoms that can be unambiguously differentiated from one 
another.  In addition, the symptoms should be considered primary rather 
than derivative or secondary features. Finally, to optimize content validity, 
items should sample from diverse realms of functioning such as cognitive, 
affective, social, and communicative. 
 
Administration of the SCI-PANSS 
 The Positive and Negative Syndrome Scale (PANSS) was developed 
initially as a pencil and paper rating system to evaluate the severity of 
symptoms associated with schizophrenia (Kay, Fiszbein, & Opler, 1987). The 
PANSS was a thirty item, seven point rating instrument that was carefully 
operationalized to assess these symptoms. The PANSS was initially 
formulated as a special adaptation of two psychiatric rating scales; the Brief 
Psychiatric Rating Scale (BPRS) (Overall & Gorham, 1962) and the 
Psychopathology Rating Scale (PRS) (Singh & Kay, 1975). As the PANSS 
PANSS Factor Structure   23 
evolved out of these instruments, the authors recognized the need for a 
rigorous set of guidelines to aid in eliciting data in a systematic way during 
the course of the interview (Kay, Opler, Fiszbein, 1992).  Therefore, a semi-
structured interview was developed with precise directions for the conduct of 
the evaluation. Additionally, clear definitions were developed for each 
parameter assessed and distinct criteria were defined for rating all seven 
levels of symptom severity. 
 The SCI-PANSS contains four basic scales: Positive, Negative, general 
Psychopathology, and a Composite scale (Kay, Opler, Fiszbein, 1992). The 
Positive Scale measures symptoms that are features which are not normally 
a part of the normal mental status. The Negative Scale assesses features that 
are absent from a normal mental status such as poverty of speech and 
blunted affect. A General Psychopathology Scale gauges the severity of 16 
symptoms associated with schizophrenia but not necessarily defined to be 
positive or negative in nature. The Composite Scale is a bipolar scale derived 
by subtracting the Negative Scale score from the Positive Scale score. This 
provides a measure of the preponderance of positive to negative symptoms. 
The SCI-PANSS also includes five additional scores for clusters of symptoms 
that the authors did not find to be independent syndromes but were 
descriptive of problems associated with schizophrenia. Scores are available to 
measure Anergia, Thought Disturbance, Activation, Paranoid/Belligerence, 
and Depression. 
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 SCI-PANSS ratings are based on ratings of information describing a 
user defined time period, typically the week prior to the interview. These 
ratings are based upon information gleaned from a variety of sources 
including the clinical interview, chart records, hospital staff, and family 
members. The information from multiple sources assists in the accurate 
rating of a number of items that may not immediately present in the course 
of the 30 to 45 minute interview. 
 An interview booklet guides the interview itself. This booklet contains 
prompts to systematically establish the presence then the severity of 
schizophrenia symptoms. The booklet contains both yes – no questions and 
open-ended questions. This format allows the interviewer to establish the 
existence, nature, and impact of the manifestations of each symptom. The 
interview also has a decision tree sequence so that the follow up questions 
depend upon the answer to the previous question. Often, this allows for the 
interviewer to skip out of unnecessary sections. 
 The interview is generally conducted in three stages that include a 
rapport building stage, the formal interview, and a scoring stage (Kay, Opler, 
Fiszbein, 1992). During the rapport building stage the interviewer should 
take approximately ten minuets to establish a relationship with the 
participant and allow the participant to state from the outset their areas of 
concern. The interviewer takes a non-directive and unchallenging posture, 
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allowing the participant to elaborate on current life circumstances and 
current concerns. 
 The formal interview calls for the collecting of specific information 
relevant to the thirty items. The instrument does allow for the assessor to 
conduct the interview in semi-structured manner. This allows the interviewer 
to begin with domains that may be more relevant to the participant based 
upon information gathered during the rapport building phase. The objective 
during this stage is to reliably asses the symptoms mainly from the report 
and elaboration of the participant. The severity of the symptom is weighted 
according to the person’s report of manifestation, frequency, and impact on 
daily functioning. The final stage is the rating of the thirty symptoms 
assessed by the SCI-PANSS. 
Rating The SCI-PANSS Items 
 Each of the thirty items of the SCI-PANSS is accompanied by a specific 
definition (see Appendix B). In turn, each of these definitions is accompanied 
by detailed anchor criteria for the seven rating points. The seven rating 
points represent increasing levels of severity. The rating points are labeled 
as: 
  1 – Absent 
  2 – Minimal 
  3 – Mild 
  4 – Moderate 
  5 – Moderate Severe 
  6 – Severe 
  7 - Extreme 
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 In assigning these ratings, the evaluator is encouraged to consider all 
available information. Judging by the item definition, the evaluator must 
first determine if that symptom is present. If it is absent, then the item is 
scored 1. If it is present then the evaluator must determine the severity of the 
symptom by referencing the criteria for the item’s anchoring points. The 
highest applicable rating point is always assigned, even if the participant 
meets criteria for lower ratings as well. The rater must use a holistic 
approach in deciding which anchoring point best characterizes the 
participants current functioning. 
 The rating points are considered to be incremental levels of symptom 
severity (Kay, Opler, Fiszbein, 1992). A rating of 2 (minimal) generally 
describes questionable or suspected pathology or behavior representative of 
the outer limits of the normal range. A rating of three (mild) denotes a 
symptom whose presence is clearly pronounced but has minimal interference 
with day to day functioning. Ratings of 4 (moderate) characterize symptoms 
that are serious problems but occur infrequently or intrude in daily life only 
to a moderate extent. The moderate severe rating of 5 indicate symptoms 
that distinctly impact functioning but are not all consuming and can be 
contained. A rating of 6(severe) defines gross psychopathology and is highly 
disruptive to daily functioning. The most serious level of 7 (extreme) 
represent symptoms that profoundly interfere with daily functioning and 
usually require supervision or assistance. Summing the items associated with 
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each domain (Positive, Negative, and General Psychopathology) derives the 
scale scores. 
 
Reliability of the SCI-PANSS 
 One of the strongest features of the SCI-PANSS is the consistent 
finding of the instrument reliably measures the symptoms of schizophrenia. 
Additionally, in multiple studies the scales are reported to be independent. In 
rare circumstances the positive and negative symptoms may show modest 
correlations. However, by extracting the shared variance with the General 
Psychopathology scale, the Positive and Negative scales consistently 
demonstrate an inverse relationship (Kay, Fiszbein, Opler, 1987). This is a 
particularly useful feature of the SCI-PANSS in that the instrument allows a 
researcher to control for the influence of affective and non-specific symptoms 
on the severity of positive and negative features.  
 The authors of the instrument reported that in the initial reliability 
assessments of the PANSS, each item correlated strongly with the 
appropriate scale total (Kay, Fiszbein, & Opler, 1987). The mean item total 
correlation’s of .62 (positive) and .70 (negative) far exceeded cross 
correlation’s of .17 (positive items with negative scale) and .18 (negative 
items with the positive scale). Alpha coefficients of single items ranged from 
.64 to .84. No gains in the alpha coefficients could be made by removing any 
items. Test – retest Pearson correlations were all significant in the positive 
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direction ranging from .60 for General Psychopathology to .80 for the Positive 
Scale. Additional assessments of inter-rater reliability demonstrated 
consistently strong correlations between .89 and .94 (Kay, Opler, 
Lindenmayer, 1988) (vonKnorring & Lindstrom, 1995). 
 The SCI-PANSS has also demonstrated to be well correlated to other 
measures of schizophrenia symptoms (Norman, et al., 1996) such as the Scale 
for the Assessment of Positive Symptoms (Andreasen, 1984) and the Scale for 
the Assessment of Negative Symptoms (Andreasen, 1983). Additionally, the 
SCI-PANSS correlates well with its predecessor (Bell et al., 1992), the Brief 
Psychiatric Rating Scale (Singh and Kay, 1974). While prior clinical 
experience does not appear to make for substantial differences in the training 
of PANSS evaluators, an inter-rater concordance rate of 80% is usually 
achieved after three training sessions (Muller, et al., 1998). 
 The SCI-PANSS is no less impressive in terms of assessments of the 
validity of the measure. There have been a large number of studies that 
demonstrate the instrument’s validity in assessing the dimensional nature of 
schizophrenia. These investigations have covered a wide range of 
independent clinical, genealogical, psychometric, and historical measures. 
These assessments of validity include discriminate and convergent validity 
(Kay, Opler, & Fiszbein, 1985; Opler & Kay, 1985; Opler, Kay, & Fiszbein, 
1987; Kay & Opler, 1987), criterion related validity (Kay, Opler, & 
Lindenmayer, 1988; Lindenmayer, Kay, & Opler, 1984), predictive validity 
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(Kay & Opler, 1985; Kay & Lindenmayer, 1987; Lindenmayer, Kay, & 
Friedman, 1986) and concurrent validity (Peralta & Cuesta, 1994). 
 
The Factor Structure of the SCI-PANSS 
 Since the publication of the SCI-PANSS, there has been a serious 
debate with regards to its factor structure. A series of factor analytic studies 
on the SCI-PANSS have demonstrated inconclusive results. While some 
authors report as few as three factors, others report as many as seven. While 
a number of studies describe a variety of models individually, few have 
sought to compare several models simultaneously. 
 In the original normative sample of 240 schizophrenics, a principle 
components factor analysis was performed to address whether the positive 
and negative symptoms constitute two major components of schizophrenia 
symptoms (Kay & Sevy, 1990). Seven orthogonal factors were revealed in this 
study accounting for 64.7% of the variance. The first two factors with 
eigenvalues greater than two were a positive and a negative factor. Two 
additional factors with eigenvalues greater than two were found that 
described an excited domain and a depressed factor. While included in 
describing a four-factor model of schizophrenia by Kay and Sevy (1990) these 
two factors were included as supplemental measures in the PANSS to be 
used for descriptive purposes of the individual. Three remaining factors 
(cognitive dysfunction, suspiciousness, and depressed) were generally 
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disregarded by Kay and Sevy (1990) in describing what they interpreted as a 
four factor model. These three factors were also included, though in altered 
form, in the symptom profile that can be utilized in scoring. The findings of 
Kay and Sevy (1990) were replicated during a drug treatment study in 
France (Peuskens, 1992). Liu and associates (1997) also reported a four-factor 
model comprised of a negative, a disorganization, an excitement, and a 
delusions/hallucinations factor. However, one critique of this study was the 
dropping of the General Pathology Scale items from the analysis. While this 
did demonstrate that the positive and negative symptoms separated into a 
total of four factors, it did not account for a large number of other negative 
symptoms, depressive symptoms, and cognitive items often related to 
schizophrenia. 
 Several studies report a five factor model of the SCI-PANSS items that 
are similar to each other (Lepine, 1991; Lindstrom & von Knorring, 1993; 
Lindenmayer, et al., 1994; and Bell, et al., 1994). The five factor solutions 
have explained between 57 to 70 percent of the total variance. This model 
includes a positive, a negative, an excited, an anxious/depressive, and a 
cognitive factor. The positive factor is comprised of delusions, unusual 
thought content, hallucinations, and grandiosity. The negative component 
was described by blunt affect, lack of spontaneity, motor retardation, poor 
rapport, emotional withdrawal, and passive social withdrawal. The excited 
factor includes hostility, uncooperativeness, poor impulse control, and 
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excitement. The anxious/depressive domain includes anxiety, guilt, and 
somatic concerns. The cognitive factor is comprised of poor attention, 
disorientation, preoccupation, conceptual disorganization, and difficulties in 
abstract thinking. The remaining eight symptoms were dropped from these 
models due to low communalities. These symptoms include suspiciousness, 
stereotyped thinking, tension, mannerism and posturing, lack of judgement, 
disturbance of volition, and active social avoidance. These particular items 
may occur with such infrequency that they are rarely seen in patient 
populations or be better accounted for by other variables (von Knorring & 
Lindstrom, 1994). 
 There are several other competing five-factor models. One alternative 
model revealed factors very similar to prior five-factor models, but the 
composition of these models was more unique (Mass, et al., 2000). After the 
initial exploratory factor analysis, five components were extracted which 
explained 68.9% of the variance. Only three items (suspiciousness, somatic 
concern, and motor retardation) were dropped due to low communalities. The 
resulting model then explained 72.3% of the variance.  
 The first factor, labeled hostile excitement, was comprised of hostility, 
excitement, poor impulse control, tension, uncooperativeness, grandiosity, 
and mannerisms. Passive social withdrawal, emotional withdrawal, blunted 
affect, poor rapport, active social avoidance, and lack of spontaneity defined 
the negative syndrome. A cognitive syndrome was comprised of difficulty in 
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abstract thinking, poor attention, and conceptual disorganization. The 
positive symptom domain was made up of delusions, hallucinations, and 
unusual thought content. Depression, guilt, and anxiety symptoms defined 
the depressive factor. 
White and associates (1997) conducted an extensive evaluation of 
PANSS models on a large sample of 1,233 schizophrenic subjects. Twenty 
models were entered into a confirmatory factor analysis. These models 
include: those described previously in this study; a one factor model reflecting 
the PANSS total score (the sum of all PANSS items); a three factor model 
implied by the PANSS positive , negative, and global pathology scores; and a 
number of unpublished models available only to the PANSS study group 
(White, et al., 1997). None of these twenty models demonstrated an adequate 
fit. The models reflective of the PANSS total score and the PANSS three 
factor model demonstrated the worst goodness of fit of all the models. 
 These authors continued by examining an exploratory factor analysis 
on this large sample. This examination revealed a five factor model, but one 
different from prior models. This model was subsequently run through an 
additional confirmatory factor analysis. Within this model five items were 
dropped due to loadings on more than two factors. Seven additional items had 
dual loadings that contributed to a moderate correlation between many of the 
five factors. The final model was a 25 item, five-factor solution. The factors 
PANSS Factor Structure   33 
were labeled positive, negative, activation, dysphoric mood, and autistic 
preoccupation. 
 The results suggest that the criteria for certain items were too diffuse 
in definition and may need revision. Specifically, these items were: lack of 
judgement, suspiciousness, active social avoidance, and disorientation.  The 
conceptual disorganization item loaded positively on the negative factor and 
loaded negatively on the autistic preoccupation factor while these two factors 
were positively correlated. This again suggested that the definition of this 
item was too diffuse in attempting to measure a broad characteristic of 
thought disorder. 
 While four of the five factors were very similar to previous models, the 
fifth was very much unlike the disorganization factor found in other 
solutions. This factor included poor attention, preoccupation, difficulty in 
abstract thought, stereotyped thinking, disturbed volition, and 
hallucinations. This is unlike disorganization factors usually described by 
inappropriate affect, thought disorder, and bizarre behavior. White suspected 
that the PANSS items may not be sensitive to the thought disorder symptoms 
given so many of these items were dropped or had dual loadings, thereby not 
detecting a disorganization factor. The multiple dual loadings were found 
with hallucinations, uncooperativeness, impaired volition, impulsivity, 
somatic concerns, poor rapport, and tension. Dual loadings are rarely found 
in exploratory factor analysis, instead being a feature of confirmatory factor 
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analysis. While these loadings may be in part caused by overlap in definitions 
of items, they also suggest that these items may have more than one causal 
influence or are correlated to the severity of other symptoms. 
 The consistent finding of a five factor model suggests that the use of 
four is too restrictive (von Knorring & Lindstrom, 1995). The use of five 
factors is given further support by indications that all five factors are 
sensitive to change during the course of psycho-pharmacological studies 
(Lindenmayer, Growchowski, & Hyman, 1995; Lindenmayer, Growchowski, 
& Mabugat, 1994). 
 The findings of the PANSS study group (White, et al., 1997) are unique 
from all other reports on the factor structure of the SCI-PANSS in that they 
encompasses a comparison of many models of the PANSS structure. There 
was one prior study utilizing confirmatory factor analysis (Cuesta & Peralta, 
1995). However, this study contained serious limitations in its findings. In 
the comparison of alternative models of positive and negative symptoms, only 
those below four factors were considered, including a null model. The null 
model, one, and two-dimensional models were not supported. The best 
goodness of fit was found for three-dimensional models that were defined by 
positive, negative, and disorganized. Little was gained by adding a fourth 
dimension. No models of five dimensions were evaluated. The generalizability 
of these results is severely limited by the use of only items within the positive 
and negative scales. This shortcoming does not allow for testing models of 
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schizophrenic symptoms that consider the role of affective, cognitive, and 
social functioning syndromes. 
 The SCI-PANSS appears to be a reliable and valid instrument to 
assess the severity of a wide range of symptoms associated with 
schizophrenia. However, the factorial validity of the SCI-PANSS is in 
question. Various reports of the factor structure of the instrument described 
conflicting models that ranged from three factors to as many as seven. While 
it has been suggested that five factors provide a balance between parsimony 
and a comprehensive description of the phenomenon of schizophrenia, the 
construction of these models vary significantly. When the models are 
compared simultaneously, no one model is clearly established as describing 
the structure of these complex symptom domains. However, the majority of 
factor analytic studies of the SCI-PANSS have derived but one model based 
upon one patient sample. There has been considerable variation across these 
studies as to the composition of these samples. While some studies used 
inpatients only, others utilized outpatients or a mixture of both. This leaves 
the findings of these studies vulnerable to variations in the samples that are 
inescapable such as some samples being in more acute stages than others. 
Only one study has compared multiple models using one sample. However, 
this study reported findings that are inconsistent with prior factor analytic 
studies. Further evaluation of the factorial validity of the SCI-PANSS is 
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needed in order to accurately describe and measure the symptoms of this 
debilitating disorder. 
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II. Method 
Overview of Research Design 
 The main goals of this proposed project are (1) to examine the factor 
structure of the PANSS rating scale in a sample of individuals diagnosed 
with schizophrenia and (2) to compare the obtained factor structure with 
previously obtained factor structures identified in the literature.  PANNS 
ratings were made on 2,358 participants drawn from psychiatric hospital 
inpatients. Participants were first administered the SCI-PANNS interview, 
and ratings on the PANNS criteria were then made. The data was first 
subjected to an exploratory factor analysis to determine the factor structure 
of the obtained data set. The resulting factor solution was then compared to 
previously described factor solutions for the PANNS using confirmatory 
factor analysis and goodness-of-fit analysis.   
 
Participants 
The study included 2,358 participants who were psychiatric inpatients. 
Participants were volunteers who agreed to participate in clinical outcome 
trials of psychotropic medication conducted at  psychiatric hospitals while 
being treated for chronic schizophrenia. While PANSS assessments were 
conducted over a long time frame, only those administered at time of 
admission to the clinical outcomes study were used for this study. The 
assessments were conducted from September 2002 through June 2004.  This 
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data was collected prior to the initiation of this study thereby making this a 
retrospective study of archival data. As this data is being used 
retrospectively, it should be noted that the description of data collection is a 
generalization of what has occurred at multiple sites by multiple researchers, 
not what done by this author.  
Inclusion Criteria: Participants are individuals diagnosed with 
schizophrenia, based on DSM-IV diagnostic criteria. Diagnoses were obtained 
based on chart information. Only those participants diagnosed with 
schizophrenia by a licensed psychiatrist were included in this study. 
Participants were enrolled based on the inclusionary criteria that they have a 
primary Axis I diagnosis of schizophrenia and be between the ages of 18 to 
65. The upper age limit of 65 was selected due to evidence of increased 
occurrence of dementia beyond that age, and the need to differentiate 
psychotic from dementia related processes.  
Exclusion Criteria: Exclusion criteria were as follows: 
 Primary Axis I diagnosis other than schizophrenia  
 Diagnosis of moderate to severe mental retardation (I.Q. score of 55 or 
below)  
 Diagnosis of organic brain syndrome 
 Current use of drugs or alcohol 
.    Non-English speaking subjects 
As the focus of this project is on the factor structure of the PANSS in 
individuals diagnosed with schizophrenia, individuals with other primary 
Axis I diagnoses, including schizo-affective disorder, were excluded.  
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Human Subjects 
 Written informed consent was obtained from all participants. A parent, 
relative or guardian was required to give consent if a participant is unable to 
legally do so. The consent form provided an explanation of the assessment 
procedure, risks, benefits, and the participant’s rights in being a part of this 
study. 
 Potential risks included the confidentiality of the participant 
information and testing results, distress caused by the sensitive nature of the 
results, and feeling uncomfortable about the study before, during, and / or 
after the interview has ended. In order to minimize potential risks, 
participant data can only be identified through code numbers instead of 
names. Participants were informed that no personnel other than those 
directly related to conducting this study had access to this coded data. The 
treatment of all participants was conducted in accordance with “The Ethical 
Principles of Psychologists and Code of Conduct” (American Psychological 
Association, 1992). 
 The consent form was individually read to each of the participants. All 
participants were told the following: (a) that they could withdraw from the 
study at any time; (b) they would have the opportunity to review the testing 
procedure with the evaluator; (c) and they would have the opportunity to 
discuss their feelings about the study and procedures used. 
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Procedure 
Screening Procedure
Participants were screened through the clinical trials admission 
criteria based upon the admission diagnosis of schizophrenia made by a 
licensed psychiatrist, and evidence of a six month drug and alcohol free 
period. Evidence for this drug free period was ascertained from chart records 
indicating clean urine drug screens performed to detect the presence of drugs 
and alcohol. 
Evaluators and Training Procedure 
 The evaluators for this study include trained psychiatric and 
psychological treatment providers on placement for graduate training or full 
time employed researcher assistants in a state psychiatric hospital. They 
were trained in the use and scoring of the SCI-PANSS by an experienced 
licensed psychologist with expertise in the utilization of the instrument. 
Training was conducted in three sessions of two hours duration each. 
Training sessions will address the theoretical foundations of the SCI-PANSS, 
the foundations for good psychiatric interviews, and the use of rating criteria 
for each of the thirty items of the PANSS.  
Training included watching videotaped model interviews as well as 
participation in mock interviews. These interviews were scored by each of the 
trainees, as well as the trainer. The set of scores were then compared. This 
was followed by discussion when the item scores are greater than one point. 
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Rehearsal of interviews and ratings continued until at least 80% concordance 
is reached between the evaluators. The psychologist responsible for training 
the evaluators provided ongoing supervision for the evaluators as they 
proceeded with the interviews.  
Interview Procedure 
Interviews were conducted under the supervision of a licensed clinical 
psychologist. At the start of the initial meeting, the evaluator explained the 
purpose of the evaluation, obtained written informed consent, and answered 
any questions the participant may have.  
 The interviewers conducted the interview as outlined in the SCI-
PANSS Manual (Kay, Opler, Fiszbein, 1992) and in accordance with the 
American Psychological Association ethics code (APA, 1992). All participants 
interviewed individually in a private room at the facility where they were 
enrolled for treatment. After obtaining the informed consent, the interviewer 
commenced administering the SCI-PANSS according to the instructions 
outlined in the SCI-PANSS manual (Kay, Opler, Fiszbein, 1992). Following 
the interview the participants were given the opportunity to ask any 
questions about the procedure and express any concerns about the study. At 
the conclusion of the interview the participant was debriefed by the evaluator 
and be given an opportunity to ask questions and express reactions to the 
testing procedure. Additionally, the evaluators conferred with the facility 
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staff regarding the individual’s functioning and review records of the 
individual’s charts as appropriate to the interview. 
If, during the course of the interview, the participant reported having 
serious suicidal or homicidal ideation with a plan / intent, the evaluator 
contacted a staff member who was required to be onsite during the 
interviews. Care would have been transferred to the facility staff who then 
became responsible for appropriate care. 
 
Ratings and Scoring 
After the interview, evaluators independently scored the individual 
items using the SCI-PANSS scoring sheet. The constructs that are evaluated 
by the PANSS can be seen in Appendix A. The items were then rated on the 
seven point rating system included with the PANSS manual. 
  
Data Analysis 
Overview of Data Analyses 
 The analysis of the data proceeded in two stages. At the outset of each 
stage there was an examination of the descriptive characteristics of the entire 
sample, including basic demographics. In addition, basic characteristics of 
the data, such as mean scores for each item, were examined in each stage. 
 Stage one of the statistical evaluation was the exploratory factor 
analysis of the SCI-PANSS items. In utilizing large data sets where 
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confirmatory factor analysis is to be used, it is common practice to randomly 
split the data set in half. One subsequent set of data is used in exploratory 
factor analysis to identify feasible factor structures. The second remaining 
data set is then used for the confirmatory factor analysis to simplify and 
refine this basic model. In this method the data sets are used in tandem to 
identify factors and build theory (Moore & Neimeyer, 1991). This analysis 
extracted the number of factors for a model that best explains the shared 
amount of variance accounted for by the variables with this particular 
sample. This determined the best fitting factor structure, and provided a 
reference for the analyses to be conducted in the second stage.  
In the second stage, a confirmatory factor analysis was performed on 
the data that stipulated several models reflected in prior studies. While the 
majority of prior studies have analyzed the goodness of fit for one only model 
using principal components analysis or exploratory factor analysis, this study 
capitalizes on the strength of CFA in comparing the goodness of fit of several 
competing models, which is a useful tool in theory testing (Bryant & Yanold, 
1995). Seven competing models were compared. 
The second stage of the analysis is perhaps the most important in 
terms of this study. The obtained factor structure from the exploratory factor 
analysis was compared to several other previously described models, as 
appropriate. These included a null model; a three factor model as outlined by 
Kay and his associates (1992); a four factor model proposed by Kay and Sevy 
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(1990), a five factor model which has been found by a number of authors 
(Lindenmayer, et al., 1995), a five factor model proposed by White and his 
colleagues, and a seven factor model as outlined by Kay and Sevy (1990).  
 
The Utility of Factor Analysis 
 Factor analysis is a data reduction technique, or more accurately, a 
dimension reducing procedure (Bryant and Yarnold, 1995). The primary 
purpose of factor analysis is to uncover the underlying structure in a data 
matrix. By defining a number of underlying dimensions, or factors, through 
examining the correlations of a large number of variables, the latent 
structure of multiple variables is described. A smaller number of underlying 
dimensions comprised of correlated variables can be uncovered. This reduces 
a multitude of variables into several dimensional constructs. All the variables 
are considered simultaneously with each related to all others in the set. This 
forms a set of factors which maximizes the explanation of entire variable set.  
Exploratory Factor Analysis (EFA) can identify a small set of synthetic 
variables, termed eigenvalues or factors. These factors explain most of the 
common variation present in the original variable. The EFA seeks to uncover 
the simplest structure of a group of continuous data. EFA works with the 
assumption that the total variance of a variable is the sum of three different 
types of variances. The common and specific variances are reliable and stable 
while the third, error variance is unreliable. The common variance is the 
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portion of total variance that is shared with other variables in the analysis. 
The specific variance is the portion of the total variance that does not 
correlate with the other variables. The error variance is inherently random 
variation. EFA seeks to find factors that maximize the amount of common 
variance. EFA does not work with any a priori constraints on the estimation 
of the number of factors to be derived. Instead, EFA provides a structure that 
is inherent in the data which best explains the variation. As such, EFA can 
be described as a model or theory building technique that proposes a 
theoretical structure of a construct. 
Confirmatory Factor Analysis (CFA) is more akin to a theory testing 
technique in that it allows for a researcher to specify a certain number of 
factors to be derived based upon preconceived thoughts about the data. The 
CFA can compare multiple, previously derived models simultaneously. The 
analyst can assess the degree to which the data meet the expected structure 
of the concept. CFA assumes that there are two main sources of variation. 
The first is due to the influence upon individual responses by latent 
structures within the concept being measured. The subject’s scores on 
observed indicators are dependent upon a structure that is brought into the 
assessment and exists a priori. The second source of variation is due to 
random error or the influence of unmeasured variables. In CFA, this source 
of variation can be partialed out leaving only that variation due to the latent 
structure. 
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III. Results 
 All analyses were conducted with the Statistical Package for the Social 
Sciences, Release 11.5 for Windows operating system. Additional analysis of 
the confirmatory factor analysis was conducted utilizing the SPSS add-on, 
AMOS which is a statistical package developed for model and theory building 
and evaluation including CFA.  
 
Description of the Complete Sample 
The complete subject pool of this investigation represented the broad 
spectrum of individuals diagnosed with psychotic disorders. A total of 2,371 
subjects were administered the SCI-PANSS. Subjects ranged from age 18 to 
65 years of age, with a mean age of 39.7 years. While there were 808 women 
participating in the study, men outnumbered women almost 2:1. Of the 
subjects for whom a subcategory was identified in their diagnosis the 
majority of subjects were diagnosed as Paranoid (1101 cases).  The 
Undifferentiated and Disorganized subtypes represented the next largest 
groups with 269 and 249 cases respectively. Residual sub-types (88 cases) 
and Catatonic (15 cases) were also represented. This suggests that the data is 
fairly representative of the full spectrum of the psychotic disorders and in 
relative proportion to epidemiological findings (APA, 1994).  
 The majority of the subjects were Caucasian, representing 74% of the 
sample.  Only five percent of the population identified themselves as African 
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– American with another 3% identified as Hispanic.  The remaining subjects 
identified themselves as Asian, mixed, or of some other racial identity. 
 There were over 1,500 cases for which a number of years since first 
diagnosis were identified.  While 14.4% of the sample had been diagnosed for 
less than one year, the average number of years since initial diagnosis was 
10.8 years. Another ten percent of the subjects had been struggling with the 
effects of schizophrenia for 25 or more years.  This also suggests that this 
sample represented a broad spectrum of individuals diagnosed with 
schizophrenia in that there were individuals for whom the diagnosis was 
recent and likely to have been in a more acute stage of the disease. Likewise 
there are a large number of subjects for whom this had been a life long 
affliction. This sample then likely reflected changes in the predominate 
symptoms throughout the course of the disorder from initial diagnosis to 
more chronic presentations. That is, the sample was not  unduly affected by 
possibly different presentations of early stages of the disorder where 
psychosis is more predominate or by those suffering more negative symptoms 
rather than the more intrusive psychosis or delusions in later stages. 
 
The Exploratory Factor Analysis 
The Sample 
 A sub-set of 1,195 subjects was selected randomly from the main data 
set with the aim of conducting an initial exploratory factor analysis. This 
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derived structure will then be compared to other models of the SCI-PANSS 
described in previous studies.  This sample includes 817 men and 378 women 
all diagnosed with schizophrenia. Subjects ranged from 18 to 65 years old 
with a men age of 39.5 years. Three quarters of the sample was comprised of 
Caucasians while five percent of the subjects were African American. The 
remaining subjects were spread between Hispanic, Asian, or other categories. 
 Diagnostic sub-types were available for all but 11 of the subjects. 
Paranoid sub-type made up the majority of the subjects (n=742). 
Undifferentiated (n=220) and Disorganized (n=165) made up the next largest 
groups of diagnostic subtypes. The remaining cases were represented by 
subjects diagnosed with Residual sub-type (n=45) and Catatonic (n=12). The 
average number of years since initial diagnosis in this sample was 10.7 years. 
 The descriptives and frequencies of the exploratory factor analysis 
sample demographics and SCI-PANSS scores can be found in Table 1 and 2. 
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Table 1 EFA Sample Demographics 
Variable  Frequency % Range Mean SD
Gender       
 Male 817 68.4    
 Female 378 31.6    
 Sub-type       
 Catatonic 12 1    
 Undifferentiated 220 18.4    
 Paranoid 742 62.1    
 Disorganized 165 13.8    
 Residual 45 45    
Race       
 African American 64 5.4    
 Asian 3 0.3    
 Caucasian 894 74.8    
 Hispanic 35 2.9    
 Mixed/Other/Unk. 199 16.6    
Age    18-65 39.53 11.9 
Years 
Since 
Diagnosis    0-43 10.67 9.13 
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Table 2 EFA Sample SCI-PANSS Scores Summary 
SCI-PANSS Items Range Mean SD
Delusions 1-7 4.08 1.47 
Conceptual 
Disorganization 1-7 3.60 1.40 
Hallucinations 1-7 3.52 1.62 
Excitement 1-7 2.58 1.34 
Grandiosity 1-7 2.26 1.45 
Suspiciousness 1-7 3.69 1.45 
Hostility 1-7 2.15 1.22 
Blunted Affect 1-7 3.68 1.35 
Emotional 
Withdrawal 1-7 3.66 1.23 
Poor Rapport 1-7 3.13 1.40 
Passive Withdrawal 1-7 3.79 1.39 
Abstract Thinking 1-7 3.88 1.46 
Poor Spontaneity 1-7 3.31 1.46 
Stereotyped 
Thinking 1-7 3.32 1.36 
Somatic Concern 1-7 2.65 1.56 
Anxiety 1-7 3.13 1.28 
Guilt Feelings 1-7 2.20 1.39 
Tension 1-7 2.96 1.26 
Posturing 1-7 2.49 1.35 
Depression 1-7 2.69 1.39 
Motor Retardation 1-7 2.61 1.35 
Uncooperativeness 1-7 2.08 1.31 
Unusual Thought 
Content 1-7 3.65 1.46 
Disorientation 1-7 1.65 1.02 
Poor Attention 1-7 2.76 1.28 
Poor Judgment 1-7 3.73 1.43 
Poor Volition 1-7 3.12 1.34 
Impulse Control 1-7 2.29 1.27 
Preoccupation 1-7 3.18 1.40 
Active social 
avoidance 1-7 3.31 1.43 
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The Exploratory Factor Analysis 
 To begin with, distribution characteristics for all SCI-PANSS items 
were calculated.  As shown in Table 3, Disorientation (Item G10) was an 
uncommon item. In all, 81% of subjects were rated with a 1 (“Absent”) or 2 
(“Minimal”). Hence the distribution of this one item demonstrates a trend 
away from normality (kurtosis = 2.67; skewness = 1.67). While this item was 
rather uncommon or absent in a majority of cases, it remained in the initial 
factor analysis with the consideration that if it is an outlier and does not 
contribute to the model, it would be unlikely to be associated with any 
derived factors. 
 In conducting factor analysis, some degree of multi-collinearity is 
desirable because the objective is to identify interrelated sets of variables 
(Hair, et. al., 1995). In keeping with this, evaluation of the data matrix 
should ensure that sufficient correlations to justify the application of factor 
analysis exist. One measure is the “measure of sampling adequacy” or MSA. 
This index ranges from zero to one, reaching one when each variable is 
perfectly predicted without error by other variables. The measure can be 
interpreted with the following guidelines (Hair, et. al., 1995): .90 or above, 
use of factor analysis is appropriate and more than a significant degree of 
multi-collinearity exists. .70 or above suggests an acceptable level of multi-
collinearity but interpretation should be done with caution; and below .50 
suggests that factor analysis is inappropriate. A Kaiser-Meyer-Olkin 
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Measure of Sampling Adequacy derived a score of .912 for this data set. This 
clearly indicates that factor analysis is appropriate and more than a 
significant degree of multi-collinearity exists. 
 Additionally, the Bartlett’s Test of Sphericity is a statistical test for the 
presence of correlations among the variables. It provides the statistical 
probability that the correlation matrix has significant correlations among at 
least some of the variables. The Bartlett’s Test of Sphericity demonstrated 
that this indeed existed with this data (X2 = 15464.39, df = 435, p=.0001). 
 To evaluate the dimensional structure of the SCI-PANSS an 
exploratory principal components analysis (PCA) with orthogonal varimax 
rotation and application of the eigenvalue criterion were carried out. The use 
of orthogonal varimax rotation was utilized in an effort to maximize the 
separation of factors (Hair, et. al., 1995). PCA extracted six components with 
eigenvalues greater than 1. This represented 59.24% of the variance. 
However, three items reached only small communalities, thus being hardly 
represented in a six factor model. That is, these items demonstrate multiple 
correlations across factors or weak correlations to any one factor. The first 
item, Lack of Judgment and Insight (G12) achieved multiple loadings on two 
factors (.406 on factor 2 and .400 on factor 3). As such, this item may be a 
constituent of both factors and likely influenced heavily by the cognitive and 
reality testing nature of these factors. The item Disorientation (G10) 
achieved a loading of .400 on the sixth factor and was the only item that 
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significantly loaded on this factor. Finally Somatic Concern (G1) achieved a 
loading of .46 on the fifth factor.  Given these low communalities, these items 
created a degree of indeterminacy in defining the factors. This suggests a re-
specification of the factor model by deriving a new factor solution with the 
non-loading variables eliminated. 
While there is some debate regarding the criteria for the significance of 
a factor loading, one general guideline is the use of “practically significant” 
findings (Hair, et. al., 1995). Generally factor loadings greater than +.30 are 
considered to meet the minimal level; loadings of +.40 are considered more 
important; and if the loadings are +.50 or greater, they are considered 
practically significant. A loading of .30 translates to approximately ten 
percent explanation of variance and a loading of .50 denotes that 25 percent 
of the variance is accounted for by the factor. These guidelines are applicable 
when the sample size is greater than 100 subjects. When considering only 
loadings greater than or equal to 0.50 as substantial (corresponding to a 
common variance between factor and variable of 25%), the following factor 
solution results (see also Table 3): 
- Factor 1 (Negative Syndrome) = Blunted Affect, Emotional 
Withdrawal, Poor Rapport, Passive Social Withdrawal, Lack of 
Spontaneity, Motor Retardation, Active Social Avoidance 
- Factor 2 (Cognitive Syndrome) = Conceptual Disorganization, 
Difficulty in Abstract Thinking, Stereotyped Thinking, Mannerisms 
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and Posturing, Poor Attention, Disturbance of Volition, 
Preoccupation. Poor Judgment 
- Factor 3 (Positive Syndrome) = Delusions, Hallucinatory Behavior, 
Grandiosity, Suspiciousness/Persecution, Unusual Thought 
Content, Poor Judgment 
- Factor 4 (Hostile Excitement Syndrome) =  Excitement, Hostility, 
Uncooperativeness, Poor Impulse Control 
- Factor 5 (Depression Syndrome) = Anxiety, Guilt Feelings, Tension, 
Depression, Somatic Concern 
- Factor 6 (Disorientation Syndrome) = Disorientation 
Of these derived factors, no single one accounted for more than fifteen 
percent of the variance (this being the first factor or Negative Syndrome. The 
second factor (Cognitive Syndrome) accounted for an additional 13% of the 
variance with the third or Positive Syndrome accounting for an additional ten 
percent. Factors 4 and 5 (Hostile excitement and Depression Syndromes 
respectively) each accounted for an additional 8% of variance. A small 
percentage of 3.8 was accounted for by the remaining sixth factor which was 
described only by the Disorientation item. 
Given the low loadings achieved by several items and the multiple 
loadings achieved by the Disorientation item with only a small amount of 
variance being accounted for by it in the sixth factor, it becomes prudent to 
remove these items in a second factor analysis. This process of eliminating 
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items with low communalities and loadings serves to build the robustness of 
the derived model. By eliminating items that contribute little or not at all to 
the model (i.e. data reduction), a clearer picture of the latent structure 
becomes clearer. 
 A second principal components analysis with orthogonal varimax 
rotation and application of the eigenvalue criterion were again carried out. 
This analysis extracted five components with eigenvalues greater than one. 
This represented 59.01% of the variance. Removal of three items appeared to 
have changed little the amount of variance explained by this model. 
 With this analysis there were no statistical outliers, items with low or 
shared communalities. With reference to the assumptions regarding multi-
collinearity, the K-M-O Measure of Sampling Adequacy resulted in a score of 
.907 which again suggests that factor analysis is appropriate. The Bartlett’s 
Tests of Sphericity ( X2= 14306.72, df = 351, p= .0001) was significant. This 
indicates that sufficient correlations were found within the correlation 
matrix. 
The resulting factor structure remained almost identical to the original 
structure, with some resulting clarity gained by the deletion of the three 
items. When considering only loadings greater than or equal to 0.50 as 
substantial (corresponding to a common variance between factor and variable 
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Table 3 PCA Factor Loadings 
   Factors    
SCI-PANSS Items 1 2 3 4 5 6
Blunted Affect 0.730      
Emotional 
Withdrawal 0.808      
Poor Rapport 0.720      
Passive Withdrawal 0.798      
Poor Spontaneity 0.753      
Motor Retardation 0.637      
Active social 
avoidance 0.626      
Conceptual 
 Disorganization 0.726     
Abstract Thinking  0.692     
Stereotyped 
Thinking  0.569     
Posturing  0.525     
Poor Attention  0.695     
Preoccupation  0.503     
Poor Volition  0.542     
Delusions   0.849    
Hallucinations   0.564    
Grandiosity   0.534    
Suspiciousness   0.633    
Unusual Thought   0.722    
Excitement    0.553   
Hostility    0.789   
Uncooperativeness    0.705   
Impulse Control    0.715   
Somatic Concern     0.460  
Anxiety     0.763  
Guilt Feelings     0.732  
Tension     0.569  
Depression     0.747  
Disorientation      0.400 
Poor Judgment  0.406 0.400    
 
PANSS Factor Structure   57 
of 30%), a five factor solution results (see also Table 4). It should be noted 
that these dimensions do not represent subtypes, but rather components that 
make up the greater concept of schizophrenia. While  factors are statistically 
independent, they can and usually do, overlap within given patients. 
 
Table 4 Revised Factor Loadings  
   Factors   
SCI-PANSS Items 1 2 3 4 5
Blunted Affect 0.744     
Emotional Withdrawal 0.801     
Poor Rapport 0.714     
Passive Withdrawal 0.789     
Poor Spontaneity 0.751     
Motor Retardation 0.673     
Active social avoidance 0.601     
Conceptual 
Disorganization  0.734    
Abstract Thinking  0.678    
Stereotyped Thinking  0.611    
Posturing  0.542    
Poor Attention  0.691    
Preoccupation  0.507    
Poor Volition  0.574    
Delusions   0.854   
Hallucinations   0.585   
Grandiosity   0.539   
Suspiciousness   0.644   
Unusual Thought Content   0.711   
Excitement    0.610  
Hostility    0.785  
Uncooperativeness    0.676  
Impulse Control    0.703  
Anxiety     0.796 
Guilt Feelings     0.723 
Tension     0.648 
Depression     0.732 
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The Confirmatory Factor Analysis 
 The remaining sub-set of 1,176 subjects that were selected randomly 
from the main data set for use in the confirmatory factor analysis. It should 
be noted that the two samples did not overlap and were comprised of 
completely different individuals. This sample included 767 men and 409 
women all diagnosed with schizophrenia. Subjects ranged from 18 to 65 years 
old with a mean age of 40.3 years. Seventy four percent (n= 868) of the 
sample was comprised of Caucasians while six percent (n= 70) of the subjects 
were African American. The remaining twenty two percent of the sample 
subjects were spread between Hispanic, Asian, or other categories. 
 Diagnostic sub-types were available for 1,168 of the subjects. Paranoid 
sub-type made up the majority of the subjects (n=732). Undifferentiated 
(n=230) and Disorganized (n=156) made up the next largest groups of 
diagnostic subtypes. The remaining cases were represented by subjects 
diagnosed with Residual sub-type (n=43) and Catatonic (n=7). The average 
number of years since initial diagnosis in this sample was 10.63 years. 
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Table 5 CFA Sample Demographics
Variable  Frequency % Range Mean SD
Gender       
 Male 767 65.2    
 Female 409 34.8    
 Sub-type       
 Catatonic 7 0.60    
 Undifferentiated 230 19.6    
 Paranoid 732 62.2    
 Disorganized 156 13.3    
 Residual 43 03.7    
Race       
 African American 70 06.0    
 Asian 2 0.20    
 Caucasian 868 73.8    
 Hispanic 41 03.5    
 Mixed/Other/Unk. 173 16.5    
Age    18-65 40.3 12.5 
Years 
Since 
Diagnosis    0-43 10.6 9.4 
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Table 6 CFA Sample SCI-PANSS Scores Summary 
SCI-PANSS Items Range Mean SD
Delusions 1-7 4.11 1.4 
Conceptual Disorganization 1-7 3.58 1.42 
Hallucinations 1-7 3.62 1.60 
Excitement 1-7 2.55 1.35 
Grandiosity 1-7 2.27 1.49 
Suspiciousness 1-7 3.67 1.49 
Hostility 1-7 2.17 1.25 
Blunted Affect 1-7 3.67 1.39 
Emotional Withdrawal 1-7 3.66 1.29 
Poor Rapport 1-7 3.20 1.41 
Passive Withdrawal 1-7 3.76 1.42 
Abstract Thinking 1-7 3.93 1.49 
Poor Spontaneity 1-7 3.39 1.47 
Stereotyped Thinking 1-7 3.35 1.37 
Somatic Concern 1-7 2.59 1.52 
Anxiety 1-7 3.08 1.29 
Guilt Feelings 1-7 2.16 1.34 
Tension 1-7 2.92 1.26 
Posturing 1-7 2.49 1.35 
Depression 1-7 2.62 1.37 
Motor Retardation 1-7 2.65 1.37 
Uncooperativeness 1-7 2.11 1.30 
Unusual Thought Content 1-7 3.72 1.44 
Disorientation 1-7 1.71 1.07 
Poor Attention 1-7 2.81 1.33 
Poor Judgment 1-7 3.80 1.41 
Poor Volition 1-7 3.16 1.38 
Impulse Control 1-7 2.31 1.27 
Preoccupation 1-7 3.22 1.40 
Active social avoidance 1-7 3.27 1.43 
 
 
 The CFA consisted of seven competing models of the SCI-PANSS factor 
structure (see Appendix D for a detailed comparison of each model’s factor 
structures. These included a three factor model as implied by the SCI-PANSS 
scoring system (Positive, Negative, and General).  This model included all 
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thirty items scored from the interview. The second model is the original four 
factor model suggested by Kay and Sevy (1992) in the development of the 
interview. As with the prior model, all thirty items were used, though in a 
different structure than reflected in a positive, negative, and general 
breakdown. Additionally, the seven factor model originally found by Kay and 
Sevy (1992), though disregarded by them, is included in this analysis. The 
five factor model with 27 items derived from exploratory factor analysis 
described previously from this study is included. Finally, two competing five 
factor models were identified. A model described by Lindmyer and his 
associates (1995) was used as representative of the most commonly derived 
model with 22 items used. The five factor model utilizing 25 items described 
by White et al (1997) was entered given its robustness and uniqueness in 
describing the factors. Finally a null model was entered that implied no 
latent dimensions among the SCI-PANSS items. 
Of the seven models tested for goodness of fit in the confirmatory factor 
analysis, five were derived empirically through EFA. Of note with each of 
these, several items were dropped due to poor or dual loadings. The three 
factor model tested was derived a priori by the authors of the SCI-PANSS 
and was thought to separate symptoms through accepted definitions of 
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positive and negative symptoms plus more general non-specific symptoms of 
schizophrenia. 
 The goal of a good model is to fit the observed data well, or in other 
words, to explain as much of the covariance present in the obtained data as 
possible within the specifications of the model. In evaluating the congruence 
between a latent structure model and observed data (i.e. goodness of fit) the 
chi-square statistic is used and the principle for interpreting it is the larger 
the chi-square, the better the fit (Bentler, 1992).  If the chi square is 
statistically significant (e.g., p<.05), then the residual matrix still has 
significant covariance in it and one may conclude that the model being tested 
does not fit the data well. If the chi-square is not statistically significant, 
then the null hypothesis is accepted, and one may conclude that the pre-
specified model fits the observed data well, leaving little covariance in the 
residual matrix. 
Typically, a non-significant X2 statistic is the criterion for a model that 
fits the data. Since substantial sample size can lead to large X2 for even good 
fitting models, conventions for adequate fit have been developed on the basis 
of comparative fit indices. Because symptom scale data contains a relatively 
high proportion of low intensity ratings that can result in violations of normal 
theory assumptions, robust statistics with Satorra-Bentler X2 and  robust 
comparative fit index were used primarily to evaluate model adequacy, 
though some consideration is given to an alternate fit index, the GFI or
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Goodness of Fit Index. These estimators have been found to hold under 
violation of distribution assumptions. Following the recommendations of 
Bentler (1992), the threshold for an adequate model fit was set at robust CFI 
= 0.90. Equality of correlation matrices was evaluated by the CFI using 
maximum likelihood normal distribution estimates. In utilizing the GFI, a 
perfect fit between model and data would generate a fit index of 1.00.  The 
goodness of fit measure that is adjusted for degrees of freedom is the 
Adjusted Goodness of Fit (AGFI). This particular index is the most 
conservative but less adaptive to any violations of distribution assumptions. 
A small and non-significant chi-square with a high AGFI (>0.8) were 
considered indicators of a well fitting model. 
 The results of the confirmatory factor analyses are presented in Table 
7. None of the seven models met criteria for an adequate fit. The largest 
robust CFI was 0.873 which is smaller than the minimum criteria (0.90) for 
an adequately fitting model. Specifically, this was the Lindenmeyer (1994) 
Five Factor model. 
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Table 7 CFA Results 
Model 
Chi-
Square df p GFI AGFI CFI 
Null 8943.04 434 <.001 0.525 0.491 0.446 
PANSS 3 Factor Model 6149.32 402 <.001 0.687 0.638 0.626 
Kay-Sevy 4 Factor 
(1992) 3583.38 269 <.001 0.777 0.731 0.733 
White 5 Factor (1997) 2230.96 265 <.001 0.859 0.827 0.841 
Lindenmeyer 5 Factor 
(1994) 1501.14 199 <.001 0.893 0.864 0.873 
Current 5 Factor 2717.83 314 <.001 0.841 0.808 0.832 
Kay Sevy 7 Factor 
(1992) 5513.17 397 <.001 0.728 0.681 0.667 
df= degrees of freedom   GFI= Goodness of Fit  AGFI= Adjusted Goodness of Fit  CFI= Comparative Fit Index 
 
 
 The first model estimated was the null model (the no latent structure 
model), which revealed a relatively large and highly significant chi-square 
and low goodness of fit indices. These data indicated that a model assuming 
no latent structure underlying schizophrenic symptomatology fit the data 
poorly, and in fact, they suggested that the presence of a latent structure was 
likely.  That is, to assume no latent structure is a worse crime than under-
specifying a latent structure. 
 The three factor model suggested by the structure of the SCI-PANSS 
scoring (Positive, Negative, and General dimensions) as developed by its 
authors (Kay, et al, 1992) resulted in an under-identified model (X2=6149.32, 
df = 402, p < .001, GFI= 0.687, CFI = 0.626). The observed data demonstrated 
a very poor fit to this model. This strongly demonstrated that greater 
refinement is necessary in identifying fewer constraints on the model while 
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identifying more endogenous variables (i.e. the unobserved variables defined 
by the observed data) described by the actual observations. 
 Likewise, the seven factor model (Kay and Sevy, 1992) resulted in an 
over identified model that also did not fit the observed data well (X2= 
5513.17, df = 397, p < .001, GFI= 0.728, CFI = 0.667). That is, too many 
factors were identified. These factors were the endogenous variables or 
variables that were described by the observed variables (i.e., the SCI-PANSS 
items). The poor fit suggested that too many of the observed variables which 
co-vary with each other were separated into separate factors. This separation 
removed from the results a more meaningful and representative structure.  
Kay and Sevy (1992) had reduced this seven factor model to a four 
factor model of positive, negative, anxiety/depression, and cognitive 
dimensions. This model too resulted in a poorly fitting model well (X2= 
3583.38, df = 269, p < .001, GFI= 0.777, CFI = 0.733). This variation of their 
proposed latent structure of schizophrenia symptomatology appeared to 
reflect an under-specification of the symptom dimensions.  
 These results suggested that a five factor model is superior to a three, 
four or seven factor model of schizophrenia symptomology. However, the 
three five factor models evaluated appeared very similar with regard to their 
goodness of fit. Each of these five factor models though resulted in significant 
chi-square values in the confirmatory factor analysis. This indicated that 
further refinement of these models, regardless of which has the absolute best 
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fit, is still warranted.  Further exploration and testing of their chi-square 
values is warranted to distinguish the best fitting model. When the three 
models were compared the incremental chi-square was statistically 
significant in each case: 
  X2 Lindenmeyer, Current model = 1216.69, df =115, p<.001 
  X2 Lindenmeyer, White = 729.82, df= 66, p<.001 
  X2 White, current model= 486.87, df = 49, p<.001 
 One important consideration to bear in mind about these statistical 
evaluations is that the chi-square evaluates the likelihood of Model B under 
the assumption that Model A is correct (Arbuckle & Wothke, 1999). These 
results indicate that with the Lindenmeyer (1994) model, the least number of 
constraints have been placed on the model and has resulted in the best 
relative fit of all three models bearing in mind that the model can still 
improve given a CFI< 0.90.  However, the additional constraints of the White 
(1997) five factor model had less support by the data and the new five factor 
model from the previous EFA had the least, relatively speaking, of the three. 
Within these three 5 factor models, there is some overlap in the items 
included in the models. The comparison of these models can then be seen as 
reflecting variations on a theme as it were of any number of five factor 
solutions. Therefore, it is necessary to examine problems that may be 
occurring for the SCI-PANSS at the item level. 
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IV. Discussion 
 One of the most important findings of this study is the clear indication 
that a five factor syndrome conceptualization of schizophrenia 
symptomatology best reflects that latent structure of this insidious disorder. 
Schizophrenia is best described as a disorder comprised of five dimensions. 
The components that describe schizophrenia are: positive, negative, cognitive, 
excitement, and an anxiety/depressive dimension. 
 The Positive Dimension is comprised of the most active and first rank 
symptoms that define the disorder. These include: delusions and 
hallucinatory behavior, grandiosity, and unusual thought content. It is 
primarily with these symptoms that a diagnosis is made clinically of 
schizophrenia. 
 The Negative Dimension is most clearly defined by the presence of 
blunted affect, emotional withdrawal, poor rapport with others, and passive 
or apathetic social withdrawal. Additional features of the negative spectrum 
include lack of spontaneity and flow in conversation as well as motor 
retardation. This spectrum reflects the difficulties in social relatedness often 
exhibited in many schizophrenic patients. 
 The third component, or Cognitive Dimension, is marked by difficulty 
in abstract thought, difficulties in conceptual organization, and poor 
attention. This specific dimension has a number of problems with it which 
will be discussed below. However, taken as a whole, it reflects the 
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presentation of formal thought disorders often present in schizophrenia and 
the challenges presented in the production, organizing, and retention of ideas 
and constructs. 
 The Excitement Dimension is clearly defined by symptoms of hostility, 
hyper-vigilance, hyperactivity, uncooperativeness, and poor impulse control. 
Collectively, these symptoms represent the difficulties in regulating behavior 
and at times the output related to the prior syndromes. 
 Finally, the Affect or mood Dimension is marked by depression, 
anxiety, and guilt. Additionally, somatic concerns and tension refer to the 
physiological reactions to disturbances in mood. Examples of these can 
include sweating, shaking, aches and pains without physiological cause, and 
fidgeting. 
 With the reduction of the data to a five-factor or pentagonal model, 
there are several implications for the conceptualization of schizophrenia. 
First and foremost, there is a more concise definition of the disorder. This 
assists in promoting clearer clinical communication about the disorder. 
Clinicians and researchers can more concisely describe the presentation of 
the disorder and those diagnosed with it. It also serves as a guide for ongoing 
research regarding the prognosis of schizophrenia and its etiology.  
 Additionally, there have been clear indications that all five factors of 
this model are sensitive to treatment with new anti-psychotic medications 
(Lindstrom, et al., 1994). Consequently this model might be of great interest 
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in future drug studies and clinical outcomes research when differences are 
sought between more and more selective pharmacological and psychological 
treatments.  
These findings also suggest that any examination of schizophrenic sub-
types and their causes, differentiating characteristics, or sequelae ought to 
consider a five factor model consisting of positive, negative, cognitive, mood, 
and excitement symptomatological factors.  While the five factors of this 
model were distinct and constructed from co-varying items, an individual can 
be observed to experience symptoms from multiple factors. That is, multiple 
factors/dimensions can co-occur and are not exclusive in any one person. 
Unlike categories, dimensions define multiple properties that can co-occur 
within individuals (Andreasen et. al., 1994.) This then suggests that any 
attempt to classify individuals as positive or negative may be conceptually 
flawed (Dollfus, et. al, 1996), especially without consideration of at least the 
cognitive spectrum (Peralta and Cuesta, 1994). As noted by Andreasen 
(1990), the dualistic positive – negative distinction, although useful for some 
research strategies, is likely an oversimplification that needs significant 
modification and refinement.  
While the etiology of some dimensions of schizophrenia symptoms 
remains obscure (Eaton, et al., 1995), there is substantial evidence that at 
least some of the dimensions of psychopathology in schizophrenia are related 
to different patterns of regional cerebral brain flow (Liddle et al., 1992). For 
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example, disorganization is consistently associated with abnormal blood flows 
in four parts of the brain. Psychotic symptoms are associated with abnormal 
blood flow in four other separate regions of the brain. These findings are 
consistent with disruptions in interrelated but independent circuits that may 
account for differences in clinical presentation.  A heuristic approach into the 
etiology of schizophrenia would be to regard each of the five symptom 
dimensions as representing a distinct pathophysiology Andreasen, et al., 
1995).  
 The results also implicated some problems with the validity of the SCI-
PANSS as the dimensions are currently configured when used to assess 
symptoms of schizophrenia. All the models evaluated in this confirmatory 
factor analysis, several of which figure dominantly in the literature, failed to 
meet CFA criteria for a model with adequate fit to a very large sample of 
empirical data. The three factor model (Kay, et al, 1992) with all 30 items 
utilized in the SCI-PANSS scoring was among the models with the poorest fit 
to empirical data.  
 There are several results from this large scale study that have 
implications for revision of the SCI-PANSS items. Review of the items and 
which factor they loaded on can readily demonstrate the most troublesome 
items. Some items loaded inconsistently across several studies.  One specific 
item, Lack of Judgment and Insight (G12) failed entirely to load on any 
factors across a number of studies.  With this particular item, a lack in clarity 
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in definition may be the source of the diffuse character of ratings (White, et 
al., 1997). “Lack of Judgment and Insight” combines into a single rating 
components of general social judgment, insight into the disorder, and the 
acceptance of the need for treatment. It may well be that these are in and of 
themselves discrete phenomenon. 
 The “Disorientation Item (G10) was only reflected in the Lindenmeyer 
model (1994) as part of the cognitive syndrome. The source of the diffuse 
loadings for the disorientation item may be a lack of clarity in definition of 
alternative levels of disorientation which compress evaluations of persons 
place and time at several levels (White, et al., 1997). An alternative approach 
to this problem is to rate the severity of disorientation as a progression first 
for time, then place, and lastly and most severely for person (Berg,1988). 
 Another item that infrequently loads on any factor across studies is 
G16 or ‘Active Social Avoidance”.  The lower anchor points reflect social 
patterns of being ill at ease with others, a preference to spend time alone, and 
participation in social functions only when required. The upper limits of this 
item are then suddenly described as few or no social activities due to fear or 
hostility of others especially if due to delusions. This particular item may lack 
in any discriminate validity by merging social skills deficits due to thought 
disorder at a moderate level or in more sever cases due directly due to active 
psychosis (Toomey et al., 1997). Alternatively, is the lack of social interaction 
and its severity due to other sequelae of the disorder or social phobias? Or 
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possibly an awareness of the disorder and the sense of embarrassment or 
social stigma attached to schizophrenia. Clearly, different routes of 
pathogeneses of this item could yield very different scorings and overlap of 
other items with this (i.e. delusions) could contaminate the scoring of this 
item (Mueser et al., 1994). 
 The rating of “Suspiciousness and Persecution” demonstrated very 
inconsistent loading across studies. It only loaded significantly in the EFA 
model derived in this study. Again, definitional issues may play an influence 
in rating this item. However, it may be that the subjective experience of 
suspiciousness or of being persecuted is typically a flavor of delusions rather 
than a discrete category in itself (Toomey et al., 1997). As such, it could be 
strongly influenced by large percentage of a sample being comprised of the 
DSM-IV subtype of Paranoid. However, it should be noted that problems with 
this particular item may stem from methodological difficulties of the studies 
rather than any intrinsic definitional problems with the item. That is, a 
selection bias may occur in terms of some subjects not agreeing or choosing 
not to participate based on their own suspiciousness or sense of paranoia. 
 While several studies have identified “Conceptual Disorganization” as 
a symptom of the cognitive syndrome and others as part of the positive 
syndrome, there are serious concerns with this item. The fundamental 
problem with this item derives from the attempt to scale the multi-
dimensional construct of thought disorder into a single item (White, et al., 
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1997). As presently defined the anchor point for “mild conceptual 
disorganization” includes evidence of circumstantial or tangential thinking 
(positive thought disorder) but at the upper end of the scale anchors define a 
negative thought disorder (mutism). However, deletion of conceptual 
disorganization from a dimension or the whole latent structure, results in a 
scale lacking any assessment of formal thought disorder, which is clearly a 
primary feature of schizophrenia (APA, 1994). Additional measures of 
thought disorder are needed for this scale to validly assess schizophrenia.  
 The item of “Stereotyped Thinking” (N7) measures on the lower end a 
rigidity of beliefs which in itself may be influenced by delusions or other 
psychotic processes. At the upper end, communication is severely restricted 
by repetitiveness or limitations in phrasing which may well be mediated by 
psychosis or a formal thought disorder (Toomey, et al., 1997). Adding further 
complexity to this dimension is the common presentation of inappropriate 
affect in schizophrenia. While often considered a part of conceptual 
disorganization it is not considered as a part of this scale nor is it considered 
independently (White, et al., 1997). This complexity, on the face of it, would 
suggest that not all conceptual disorganization factors are equivalent. 
 The inconsistent loadings of “Somatic Concerns” (G1) across factor 
analytic studies may demonstrate less of a problem with definitional issues 
than it does of causality. That is, this item combines elements of somatic 
concern that are common in dysphoric and anxious moods with somatic 
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delusions that often occur with active positive symptoms (Francis, First, & 
Pincus, 1995). Clearer guidelines for the differential decisions regarding this 
rating are likely needed in the interview stage and ratings. 
 It is here that this study meets with certain limitations. The process of 
factor analysis certainly allows for additional models that could be entered in 
different variations of entering or removing the most controversial items. 
However, this would require an enormous number of variations, numbering 
well into the hundreds or thousands. Within any derived factor structure, the 
removal or dropping of any number of items in refining a model can have 
significant even dramatic effects on the number of factors. Additionally, 
further elaboration of the five factor model needs to occur at the item level. 
Specifically, there needs to be further defining of certain items as previously 
described or the inclusion of more items to adequately describe more complex, 
multi-dimensional items such as conceptual disorganization (White, et al., 
1997). Without this being done, little more can be gained in adjusting the five 
factor models of schizophrenia. 
 It may be difficult to compare the findings of this study directly with 
those of other studies that used assessment scales other than the SCI-
PANSS. This is due to the fact that the factor structure of symptoms depends 
highly on the rating instrument used for assessing the symptoms. 
Schizophrenic symptoms assessed with other rating scales likely result in a 
different factor structure (Dollfus, et al., 1996). The only exception to this, of 
PANSS Factor Structure   75 
course, is if the other assessments utilized similar criteria, items, and 
constructs thereby generating some degree of concurrent validity. 
 One limitation of the method of evaluating latent structures involves 
the statistical methodology utilized in this study. Factor analysis is a data 
reduction method that shows which items are highly correlated with each 
other (Grimm and Yarnold, 1995). Demonstrating that they co-occur does not 
prove a conceptual or an etiological relationship. One cannot infer from the 
results of factor analysis that these items have a common mechanism nor 
does it imply the existence of diagnostic sub-types. 
 The agreement to participate in drug trials by a group of individuals 
diagnosed with schizophrenia may have presented an element of selection 
bias into the data pool. As noted earlier in terms of suspiciousness and 
persecution, individuals manifesting these symptoms may refuse to 
participate in research based upon the very nature of paranoia. Additionally, 
many individuals who exhibit profound difficulties in abstract thought, 
disorientation, and / or lack the ability to provide informed consent may not 
be represented in this study. They may have been underrepresented due to 
their inability to enter the drug trials without the ability to consent to the 
original treatment. This selection bias may have had some effect on reducing 
the heterogeneity of the sample. This reduction in heterogeneity in turn may 
reduce the amount of variance accounted for in the final solutions. 
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 Statistical analysis of psychiatric rating scales seeks to refine insights 
into the dimensions of schizophrenia based upon clinical observation. The 
test of the validity of defined dimensions remains the same; a guide to 
research on etiology and prognosis, detection of clinical change, and concise 
clinical description of the disorder useful in clinical communication. 
Compared to other proposed models for the SCI-PANSS, a pentagonal 
structural model of schizophrenia described in this study most closely meets 
empirical criteria for increased precision of measurement. The model is more 
complex than the earliest described models of schizophrenia. The complexity 
of the model is a function of the wide range of symptoms examined and the 
precision of confirmatory factor analysis (White, et al., 1997). 
 
 
 
 
 
 
 
 
 
 
 
PANSS Factor Structure   77 
V. Conclusion and Summary 
 Schizophrenia is a chronic and debilitating disorder marked by the 
manifestation of a complex set of symptoms.  Individuals diagnosed with 
schizophrenia typically respond to hallucinatory behavior and unshakeable 
delusions. Cognitive abilities and social interactions become severely 
impaired. Additionally, there are disturbances in subjective mood often 
related to the direct and indirect sequelae of the disorder. Its cost to 
individuals and society are extreme. The individual distress and financial 
costs touching many lives has certainly brought schizophrenia to the 
forefront of psychological and pharmacological research for decades. 
 While volumes have been written about schizophrenia, the increase in 
knowledge leads to the need for fine tuning of definitional issues and the 
description of the disorder. While early definitions of schizophrenia focused 
on a dual process theory, current evidence suggests that it is far more 
complex than this. Yet research needs to find a sense of clarity balanced with 
completeness in describing this disorder in a way that reflects naturally 
occurring phenomena.  
 This study helps build upon earlier foundations that suggest that 
schizophrenia is likely comprised of five syndromes that complete a 
pentagonal model of this illness. These syndromes are likely co-occurring 
with independent pathogenic routes. Their interactions likely make 
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schizophrenia as debilitating as it is. These syndromes can be described as 
positive, negative, cognitive, excitement, and mood related. 
 The clarity of the definitions of syndromes and the latent structure of 
schizophrenia serves many purposes. Chief among them is and accurate and 
clear description of the disorder. This promotes clearer clinical and scientific 
communication regarding etiology, treatment, and prognosis. Future work 
may lead to a clearer understanding of clinical sub-types. Clearly, the 
progress in pharmacological treatment targeting multiple symptoms 
warrants a clearer understanding of the many dimensions of schizophrenia 
 However, there remains the need for further specification of these 
models. Further clarity is needed in definitional issues of some criteria. 
Others, especially in terms of symptoms of thought disorder, are need of 
isolation of specific components as multiple domains of cognitive related 
symptoms. 
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Appendix A 
 
 
 
 
Items represented in the positive and negative syndrome scale 
Positive Syndrome Scale 
P1. Delusions 
P2. Conceptual Disorganization 
P3. Hallucinatory Behavior 
P4. Excitement 
P5. Grandiosity 
P6. Suspiciousness/Persecution 
P7. Hostility 
 
Negative Syndrome Scale 
N1. Blunted Affect 
N2. Emotional Withdrawal 
N3. Poor Rapport 
N4. Passive/apathetic social withdrawal 
N5. Difficulty in abstract thinking 
N6. Lack of spontaneity and flow of conversation 
N7. Stereotyped thinking 
 
General Psychopathology Scale 
G1. Somatic concern 
G2. Anxiety 
G3. Guilt feelings 
G4. Tension 
G5. Mannerisms and posturing 
G6. Depression 
G7. Motor retardation 
G8. Uncooperativeness 
G9. Unusual thought content 
G10. Disorientation 
G11. Poor attention 
G12. Lack of judgement and insight 
G13. Disturbance of volition 
G14. Poor impulse control 
G15. Preoccupation 
G16. Active social avoidance 
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Appendix B 
 
 
 
 
Sample item from the PANSS 
 
P3. Hallucinatory behavior 
 
Definition 
 Verbal report or behavior indicating perceptions which are not 
generated by external stimuli. These may occur in the auditory, visual, 
olfactory, or somatic realms. 
 
Basis for Rating 
 Verbal report and physical manifestations during the course of 
interview as well as reports of behaviors by primary care workers or family. 
 
1. Absent. Definition does not apply. 
2. Minimal. Questionable pathology; may be at the upper extreme of 
normal limits. 
3. Mild. One or two clearly formed but infrequent hallucinations, or 
else a number of vague abnormal perceptions which do not result in 
distortions of thinking or behavior. 
4. Moderate. Hallucinations occur frequently but not continuously, 
and the patient’s thinking and behavior are affected only to a minor 
extent. 
5. Moderate severe. Hallucinations are frequent, may involve more 
than one sensory modality, and tend to distort thinking and/or 
disrupt behavior. Patient may have a delusional interpretation of 
these experiences and respond to them emotionally and, on 
occasion, verbally as well. 
6. Severe. Hallucinations are present almost continuously, causing 
major disruption of thinking and behavior. Patient treats these as 
real perceptions, and functioning is impeded by frequent emotional 
and verbal responses to them. 
7. Extreme. Patient is almost totally preoccupied with hallucinations, 
which virtually dominate thinking and behavior. Hallucinations are 
provided a rigid delusional interpretation and provoke verbal and 
behavioral responses, including obedience to command 
hallucination. 
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Appendix C 
 
 
 
 
The Structured Clinical Interview for the Positive and 
Negative Syndrome Scale 
(SCI-PANSS) 
 
Patient Name: 
Interviewer: 
Date: 
 
Data on Lack of Spontaneity and Flow of Conversation,” (N6) “Poor 
Rapport,” (N3) and “Conceptual Disorganization” (P2) 
 
“Hi, I’m… We’re going to be spending the next 30 to 40 minuets talking about 
you and your reasons for being here. Maybe you can start out by telling me 
something about yourself and your background?” 
 
(Instructions to interviewer: Allow at least 5 minuets for a non-directive phase 
serving to establish rapport in the context of an overview before preceding to 
the specific questions listed below.) 
 
Data on “Anxiety” (G2) 
Have you been feeling worried or nervous in the past week? 
 IF NO: Would you say that you’re usually calm and relaxed? 
IF YES: What’s been making you feel nervous (worried, uncalm, 
unrelaxed)? 
 Just how nervous have you been feeling? 
 Have you been shaking at times, or has your heart been racing? 
 Do you get into a state of panic? 
 Has your sleep, eating, or participation in activities been affected? 
 
Data on “Delusions” (P1) and “Unusual Thought Content” (G9) 
Have things been going well for you? 
Has anything been bothering you lately?  
Can you tell me something about your thoughts on life and its purpose? 
Do you follow a particular philosophy? 
Some people tell me they believe in the Devil; what do you think? 
Can you read other people’s minds? 
 IF YES: How does this work? 
Can other people read your mind? 
 IF YES: How can they do that? 
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 Is there any reason that someone would want to read your mind? 
Who controls your thoughts? 
Data on “Suspiciousness/Persecution,” (P6) “Passive/Apathetic Social 
Withdrawal,” (N4) “Active Social Avoidance,” (G16) and “Poor 
Impulse Control” (G14) 
How do you spend your time these days? 
Do you prefer to be alone? 
Do you join in activities with others? 
 IF NO: Why not?...Are you afraid of people, or do you dislike them? 
  IF YES: Can you explain? 
 IF YES: Tell me about it. 
Do you have many friends? 
 IF NO: Just a few? 
  IF NO: Any?...Why? 
  IF YES: Why just a few friends? 
 IF YES: Close friends? 
  IF NO: Why not? 
Do you feel that you ca trust most people? 
 IF NO: Why not? 
Are there some people in particular that you don’t trust? 
 IF YES: Can you tell me who they are? 
 Why don’t you trust people (or name specific person)? 
IF “DON’T KNOW” OR “DON’T WANT TO SAY”: Do you have 
good reason not to trust…? 
 Is there something that…did to you? 
 Perhaps might do to you now? 
  IF YES: Can you explain to me? 
Do you get along with others? 
 IF NO: What’s the problem? 
Do you have a quick temper? 
Do you get into fights? 
 IF YES: How do these fights start? 
 Tell me about these fights. 
 How often does this happen? 
Do you sometimes lose control of yourself? 
Do you like most people? 
 IF NO: Why not? 
Are there perhaps some people who don’t like you? 
 IF YES: For what reason? 
Do others talk about you behind your back? 
 IF YES: What do they say about you? 
 Why? 
Does anyone ever spy on you or plot against you? 
Do you sometimes feel in danger? 
PANSS Factor Structure   89 
 IF YES: would you say that your life is in danger? 
Is someone thinking of harming you or even perhaps thinking of killing 
you? 
Have you gone to the police for help? 
Do you sometimes take matters into your own hands or take action on 
those who might harm you? 
 IF YES: What have you done? 
 
Data on “Hallucinatory Behavior” (P3) and associated delusions 
Do you once in a while have a strange or unusual experience? 
Sometimes people tell me that they can hear noises or voices inside their 
head that others can’t hear. What about you? 
IF NO: Do you sometimes receive personal communications from the 
radio or TV? 
  IF NO: From God or the Devil? 
 IF YES: What do you hear? 
 Are these as clear and loud as my voice? 
 How often do you hear these voices (noises, messages, etc.)? 
 Does this happen at a particular time of day or all the time? 
 IF HEARING VOICES: Can you recognize whose voices these are? 
 What do the voices say? 
 Are the voices good or bad? 
 Pleasant or unpleasant? 
 Do the voices interrupt your thinking or your activities? 
 Do they sometimes give you orders or instructions? 
  IF YES: For example? 
  Do you usually obey these orders (instructions)? 
What do you make of these voices (or noises): where do they come from? 
Why do you have these experiences? 
Do ordinary things sometimes look strange and distorted to you? 
Do you sometimes have “visions” or see things others can’t see? 
 IF YES: For example? 
 Do these visions seem very real or life like? 
 How often do you have these experiences? 
Do you sometimes smell things that are unusual or that others don’t smell? 
 IF YES: Please explain. 
Do you get any strange or unusual sensations from inside your body? 
 IF YES: Tell me about this. 
 
Data on “Somatic Concern” (G1) 
How have you been feeling in terms of your health? 
 IF OTHER THAN” GOOD”: What has been troubling you? 
 IF “GOOD”: Do you consider yourself in top health? 
 IF NO: What has been troubling you? 
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Do you have any medical illness or disease? 
Has any part of your body been troubling you? 
 IF NO: how is your head? Your heart? Stomach? The rest of your body? 
 IF YES: Could you explain? 
Have your head or body changed in shape or size? 
 IF YES: Please explain. 
 What is causing these changes? 
 
Data on “Depression” (G6) 
How has your mood been in the past week: mostly good, mostly bad? 
IF MOSTLY GOOD: Have there been times in the last week that you 
were feeling sad or unhappy? IF YES, NEXT QUESTION: 
IF ‘MOSTLY BAD”: Is there something in particular that is making 
you sad? 
How often do you feel sad? 
 Just how sad have you been feeling? 
 Have you been crying lately? 
 Has your mood in any way affected your sleep? 
 Has it affected your appetite? 
 Do you participate less in activities on account of your mood? 
 Have you had any thoughts of harming yourself? 
  IF YES: Any thoughts about ending your life? 
   IF YES: Have you attempted suicide? 
 
Data on “Guilt Feelings” (G3) and “Grandiosity” (P5) 
If you were to compare yourself to the average person, how would you come 
out: a little better, maybe a little worse, or about the same? 
IF WORSE: Worse in what ways? 
  Just how do you feel about yourself? 
 IF BETTER: Better in what ways? 
 IF ABOUT THE SAME: Are you special in some ways? 
  IF YES: In what ways? 
  Would you consider yourself gifted? 
 Do you have any talents or abilities that most people don’t have? 
  IF YES: Please explain. 
 Do you have any special powers? 
  IF YES: What are these? 
  Where do these powers come from? 
Do you have extrasensory perception (ESP), or can you read other 
people’s minds? 
 Are you very wealthy? 
  IF YES: Explain please. 
 Can you be considered to be very bright? 
  IF YES: Why would you say so? 
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  Would you describe yourself as famous? 
Would some people recognize you from TV, radio, or the newspaper? 
  IF YES: Can you tell me about it? 
 Are you a religious person? 
  IF YES: are you close to God? 
   IF YES: Did God assign you some special role or purpose? 
   Can you be considered one of God’s messengers or angels? 
IF YES: What special powers do you have as God’s 
messenger (angel)? 
   Do you perhaps consider yourself to be God? 
 Do you have a special mission in life? 
  IF YES: What is that mission? 
  Who assigned you that mission? 
Did you ever do something wrong – something you felt bad or guilty 
about? 
  IF YES: Just how much does that bother you now? 
  Do you feel that you deserve punishment for that? 
   IF YES: What kind of punishment do you deserve? 
   Have you at times thought of punishing yourself? 
IF YES: Have you ever acted on these thoughts of 
punishing yourself? 
 
Data on “Disorientation” (G10) 
Can you tell me what is today’s date (i.e. the day month, and year)? 
What is the name of the place you are in now? 
(If hospitalized :) What ward are you on? 
What is the address of where you stay now? 
If someone had to reach you by phone, what number would that person call? 
What is the name of the doctor that is treating you? 
(If hospitalized :) Can you tell me who else is on staff and what they do? 
Do you know who is now the President? 
Who is our Governor? 
Who is the Mayor of this city? 
 
Data on “Difficulty in Abstract Thinking” (N5) 
I’m going to now say a pair of words, and I’d like you to tell me in what 
important way they are alike. Let’s start, for example, with the words “apple” 
and “banana”. How are they alike…what do they have in common? 
 IF “THEY ARE BOTH FRUIT”: Good. Now what about…? 
(Select three other items from the Similarities list at varying levels of 
difficulty from Appendix A.) 
 
IF AN ANSWER IS GIVEN THAT IS CONCRETE, TANGENTIAL, OR 
IDIOSYNCRATIC, E.G., “THEY BOTH HAVE SKINS,” “YOU CAN EAT 
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THEM,” “THEY’RE SMALL,” OR “MONKEYS LIKE THEM”: Ok, but they’re 
both fruit. Now how about…and…: how are these alike? 
(Select three other items from the Similarities list at varying levels of 
difficulty from Appendix A.) 
 
Appendix A 
1. How are a ball and an orange alike? 
2. Apple and banana? 
3. Pencil and pen? 
4. Nickel and dime? 
5. Table and chair? 
6. Tiger and elephant? 
7. Hat and shirt? 
8. Bus and train? 
9. Arm and leg? 
10. Rose and tulip? 
11. Uncle and cousin? 
12. The sun and the moon? 
13. Painting and poem? 
14. Hilltop and valley? 
15. Air and water? 
16. Peace and prosperity? 
 
Note on Appendix A:  Similarities are generally assessed by sampling four 
of the items at different levels of difficulty (i.e., one item selected from 
each quarter of the full set). When using the PANSS longitudinally, items 
should be systematically alternated with successive interviews so as to 
provide different selections from the various levels of difficulty and thus 
minimize repetition. 
 
You have probably heard the expression, “Carrying a chip on the 
shoulder.” What does that really mean?  
There’s a very old saying, “Don’t judge a book by it’s cover.” What is the 
deeper meaning of this proverb? 
(Select two other proverbs from the list in Appendix B at varying levels of 
difficulty.) 
 
Appendix B 
What does the saying mean: 
1. “Plain as the nose on your face”. 
2. “Carrying a chip on your shoulder”. 
3. “Two heads are better than one”. 
4. “Two many cooks spoil the broth”. 
5. “Don’t judge a book by its cover”. 
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6. “One man’s food is another man’s poison”. 
7. “All that glitters is not gold”. 
8. “Don’t cross the bridge until you come to it”. 
9. “What’s good for the gander is good for the gander”. 
10. “The grass is always greener on the other side”. 
11. “Don’t keep all your eggs in one basket”. 
12. “One swallow does not make the summer”. 
13. “A stitch in time saves nine”. 
14. “A rolling stone gathers no moss”. 
15. “The acorn never falls far from the tree”. 
16. “People who live in glass houses should not throw stones at others”. 
 
Note on Appendix B: Proverb interpretation is generally assessed by 
sampling four of the items at different levels of difficulty (i.e., one item 
selected from each quarter of the full set). When using the PANSS 
longitudinally, items should be systematically alternated with successive 
interviews so as to provide different selections from the various levels of 
difficulty and thus minimize repetition. 
 
Data on “Lack of Judgment and Insights” (G12) 
How long have you been in the hospital (clinical, etc.)? 
Why did you come to the hospital (clinic, etc.)? 
Did you need to be in the hospital (clinic, etc.)? 
 IF NO: Did you have a problem that needed treatment? 
IF YES: Would you ay that you had a psychiatric or mental 
problem? 
IF YES: Why?...would you say that you had a psychiatric or mental 
problem? 
  IF YES: Can you tell me what is consists of? 
  IF YES: In your own opinion, do you need to be taking medicine? 
 IF NO: 
 (If medicated :) Why then are you taking medication. 
 (If undedicated:) Why are you still in the hospital (clinic, etc.) 
 IF YES: Why?...Does the medicine help you in some way? 
Do you at this time have any psychiatric or mental problems? 
 IF NO: For what reason are you still in the hospital (clinic, etc.)? 
 IF YES: Please explain. 
 Just how serious are these problems? 
 (If hospitalized:) 
  Are you ready yet for discharge from the hospital? 
Do you think you’ll be taking medicine for your problems after 
discharge? 
What are you’re future plans? 
What about you’re longer range goals? 
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Appendix D 
 
 
 
 
The CFA Compared Factor Structures       
Models PANSS Positive              
  P1 P2 P3 P4 P5 P6 P7          
Null*                 
PANSS 3 Factor P P P P P P P          
Kay Sevy 4 Factor P  P E P  E          
Lindenmeyer 5 Factor P C P E P  E          
Current 5 Factor P C P E P P E          
White 5 Factor** P  P E P  E          
Kay Sevy 7 Factor P C P E P S E          
                 
Models PANSS Negative              
  N1 N2 N3 N4 N5 N6 N7          
Null*                 
PANSS 3 Factor N N N N N N N          
Kay Sevy 4 Factor N N N N  N           
Lindenmeyer 5 Factor N N N N C N           
Current 5 Factor N N N N C N C          
White 5 Factor** N N N N C N C          
Kay Sevy 7 Factor N N N N C N St          
                 
Models PANSS General                       
  G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 G12 G13 G14 G15 G16 
Null*                 
PANSS 3 Factor G G G G G G G G G G G G G G G G 
Kay Sevy 4 Factor A A A E N A N E P  N P N E A N 
Lindenmeyer 5 Factor A A A    N E P C C   E C  
Current 5 Factor  A A A C A N E P  C  C E C N 
White 5 Factor** A A A A N A N E P  C  C E C  
Kay Sevy 7 Factor A A A E N A N E P C N P N E A N 
* Each of the SCI-PANSS items was considered as an independent dimension     
**In White (1997) the Cognitive dimension was titled Autistic and the Excitement dimension titled Activation 
Key: P = Positive,  N = Negative,  C = Cognitive,  E = Excitement,  A = Affect/Anxiety/Depressive,  E = Excitement,  
        G = General, St = Stereotyped,  S = Suspicious          
 
--------------------------------------------------------------------------------------------------------------------------------- 
 
The above table lists all 7 models of the SCI-PANSS that were entered in the 
confirmatory factor analysis. Each item (symptom) of the SCI-PANSS is listed. Each 
item is designated by letter to the factor structure of each model. Blank cells indicate that 
the item was dropped from the final factor structure. In the CFA, each model was entered 
using the factor structures described above. 
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